# pathway_nodes

date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,985
first_seen: 2021-06-23
last_seen: 2024-03-25
first_seen_parent: 2020-01-18
last_seen_parent: 2024-11-16
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 427.5, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 4.5 weekly interval (103.5 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,642
first_seen: 2020-06-20
last_seen: 2024-05-29
first_seen_parent: 2019-06-14
last_seen_parent: 2024-05-29
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 141.2, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 5.0 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £3,027
first_seen: 2020-04-10
last_seen: 2024-04-27
first_seen_parent: 2020-07-04
last_seen_parent: 2024-06-29
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 28 times with a 11.2 weekly interval (313.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 6.3 weekly interval (75.6 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 88.2, "avg_administrations": 5}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 168.6, "avg_administrations": 24}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,518
first_seen: 2021-01-17
last_seen: 2025-09-29
first_seen_parent: 2018-08-17
last_seen_parent: 2024-08-01
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 458.2, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 9.9 weekly interval (118.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,809
first_seen: 2021-05-23
last_seen: 2025-08-23
first_seen_parent: 2021-08-23
last_seen_parent: 2024-02-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 5 times with a 5.2 weekly interval (26.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16 times with a 2.8 weekly interval (44.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 286.5, "avg_administrations": 8}, {"drug": "SECUKINUMAB", "avg_dose_mg": 410.1, "avg_administrations": 17}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,200
first_seen: 2022-11-07
last_seen: 2025-09-08
first_seen_parent: 2018-04-14
last_seen_parent: 2024-05-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 11.1 weekly interval (188.7 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 17 times with a 8.0 weekly interval (136.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 138.5, "avg_administrations": 8}, {"drug": "BARICITINIB", "avg_dose_mg": 88.7, "avg_administrations": 16}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,804
first_seen: 2019-01-30
last_seen: 2024-01-15
first_seen_parent: 2020-02-11
last_seen_parent: 2024-11-28
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 72.4, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 6.3 weekly interval (100.8 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,241
first_seen: 2020-11-08
last_seen: 2024-05-10
first_seen_parent: 2018-02-09
last_seen_parent: 2024-02-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 80.2, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 9.2 weekly interval (202.4 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £24,915
first_seen: 2019-02-07
last_seen: 2025-07-24
first_seen_parent: 2019-01-21
last_seen_parent: 2024-05-18
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 122.8, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7 times with a 9.9 weekly interval (69.3 weeks total treatment length)


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,383
first_seen: 2020-02-04
last_seen: 2024-02-07
first_seen_parent: 2019-01-25
last_seen_parent: 2024-07-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 8 times with a 2.2 weekly interval (17.6 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 10 times with a 9.4 weekly interval (94.0 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 319.2, "avg_administrations": 28}, {"drug": "RITUXIMAB", "avg_dose_mg": 122.2, "avg_administrations": 19}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,784
first_seen: 2021-05-29
last_seen: 2024-08-26
first_seen_parent: 2019-07-18
last_seen_parent: 2025-10-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 2.7 weekly interval (29.7 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 11.3 weekly interval (158.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 252.3, "avg_administrations": 4}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 388.3, "avg_administrations": 22}]


date_filter_id: all_6mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £24,154
first_seen: 2021-07-17
last_seen: 2025-08-02
first_seen_parent: 2018-09-08
last_seen_parent: 2025-03-28
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 318.6, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 20 times with a 4.0 weekly interval (80.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £12,093
first_seen: 2019-08-14
last_seen: 2024-01-28
first_seen_parent: 2020-04-20
last_seen_parent: 2024-10-22
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 111.1, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 12 times with a 8.8 weekly interval (105.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,687
first_seen: 2022-10-12
last_seen: 2024-02-20
first_seen_parent: 2019-06-10
last_seen_parent: 2025-12-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 7.2 weekly interval (100.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 11.9 weekly interval (119.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 369.4, "avg_administrations": 19}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 149.7, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,058
first_seen: 2021-09-26
last_seen: 2024-12-09
first_seen_parent: 2018-10-06
last_seen_parent: 2024-04-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6 times with a 2.6 weekly interval (15.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 5.9 weekly interval (100.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 297.4, "avg_administrations": 23}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 110.4, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,989
first_seen: 2020-09-19
last_seen: 2025-08-26
first_seen_parent: 2017-11-13
last_seen_parent: 2025-09-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 66.3, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 15 times with a 4.4 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,918
first_seen: 2019-07-18
last_seen: 2025-03-22
first_seen_parent: 2019-03-09
last_seen_parent: 2024-12-23
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 125.7, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 10.0 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,488
first_seen: 2019-01-20
last_seen: 2024-07-07
first_seen_parent: 2019-07-10
last_seen_parent: 2025-01-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 90.5, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 11.2 weekly interval (235.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,899
first_seen: 2021-05-26
last_seen: 2024-01-15
first_seen_parent: 2018-01-20
last_seen_parent: 2024-11-18
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 80.2, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 11.2 weekly interval (324.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £13,926
first_seen: 2021-09-17
last_seen: 2025-02-02
first_seen_parent: 2019-05-19
last_seen_parent: 2025-05-29
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 404.9, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 9.7 weekly interval (155.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,485
first_seen: 2021-03-05
last_seen: 2025-12-28
first_seen_parent: 2019-03-04
last_seen_parent: 2025-10-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 26 times with a 9.8 weekly interval (254.8 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 349.5, "avg_administrations": 8}, {"drug": "USTEKINUMAB", "avg_dose_mg": 129.6, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,815
first_seen: 2021-05-29
last_seen: 2024-12-30
first_seen_parent: 2020-02-11
last_seen_parent: 2024-10-25
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 5.1 weekly interval (81.6 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 6 times with a 6.0 weekly interval (36.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 460.1, "avg_administrations": 21}, {"drug": "SECUKINUMAB", "avg_dose_mg": 140.6, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,188
first_seen: 2018-06-06
last_seen: 2025-03-06
first_seen_parent: 2020-12-11
last_seen_parent: 2025-12-28
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 424.8, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 6.7 weekly interval (167.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £13,490
first_seen: 2020-06-14
last_seen: 2025-12-17
first_seen_parent: 2020-01-23
last_seen_parent: 2024-01-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 11.6 weekly interval (92.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 5.6 weekly interval (33.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 114.4, "avg_administrations": 18}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 90.0, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,741
first_seen: 2020-07-21
last_seen: 2025-01-22
first_seen_parent: 2019-06-27
last_seen_parent: 2025-03-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 5.6 weekly interval (44.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 2.9 weekly interval (81.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 59.4, "avg_administrations": 12}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 216.2, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £6,800
first_seen: 2021-04-12
last_seen: 2025-09-23
first_seen_parent: 2017-11-16
last_seen_parent: 2024-12-20
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 415.9, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 11.1 weekly interval (88.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,972
first_seen: 2019-08-02
last_seen: 2024-09-29
first_seen_parent: 2018-03-19
last_seen_parent: 2024-07-05
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 7.8 weekly interval (226.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 6.9 weekly interval (27.6 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 307.9, "avg_administrations": 26}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 100.3, "avg_administrations": 28}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £7,324
first_seen: 2018-03-18
last_seen: 2025-07-27
first_seen_parent: 2020-12-18
last_seen_parent: 2024-10-05
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 134.2, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 19 times with a 3.1 weekly interval (58.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,412
first_seen: 2019-11-10
last_seen: 2025-06-20
first_seen_parent: 2020-04-09
last_seen_parent: 2024-05-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 2.2 weekly interval (19.8 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 16 times with a 6.9 weekly interval (110.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 359.9, "avg_administrations": 29}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 231.0, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,220
first_seen: 2019-06-02
last_seen: 2024-07-09
first_seen_parent: 2017-02-24
last_seen_parent: 2025-02-10
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 155.0, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 10.3 weekly interval (144.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £17,981
first_seen: 2020-05-30
last_seen: 2025-01-16
first_seen_parent: 2021-04-23
last_seen_parent: 2024-04-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 10.7 weekly interval (278.2 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 6 times with a 11.5 weekly interval (69.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 254.7, "avg_administrations": 30}, {"drug": "USTEKINUMAB", "avg_dose_mg": 370.2, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,321
first_seen: 2019-03-03
last_seen: 2024-05-26
first_seen_parent: 2019-08-26
last_seen_parent: 2025-06-11
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 491.9, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 29 times with a 4.3 weekly interval (124.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,153
first_seen: 2022-06-18
last_seen: 2025-01-07
first_seen_parent: 2021-03-28
last_seen_parent: 2025-05-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 8.9 weekly interval (222.5 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 3.9 weekly interval (62.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 269.6, "avg_administrations": 5}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 137.7, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,244
first_seen: 2020-08-02
last_seen: 2025-10-05
first_seen_parent: 2019-06-14
last_seen_parent: 2024-05-30
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 461.9, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 3.5 weekly interval (49.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £21,497
first_seen: 2021-02-17
last_seen: 2024-06-03
first_seen_parent: 2020-12-16
last_seen_parent: 2024-06-16
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 348.4, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 23 times with a 7.9 weekly interval (181.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £3,611
first_seen: 2019-11-21
last_seen: 2024-07-01
first_seen_parent: 2017-07-01
last_seen_parent: 2025-11-05
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 169.0, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 7 times with a 10.5 weekly interval (73.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,770
first_seen: 2020-08-02
last_seen: 2025-03-30
first_seen_parent: 2017-04-17
last_seen_parent: 2025-03-10
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 314.9, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 8.7 weekly interval (87.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,158
first_seen: 2021-04-12
last_seen: 2025-10-12
first_seen_parent: 2018-05-13
last_seen_parent: 2025-03-22
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 245.4, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 5.3 weekly interval (100.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,696
first_seen: 2020-04-22
last_seen: 2024-04-18
first_seen_parent: 2021-09-01
last_seen_parent: 2024-01-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 4.8 weekly interval (72.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 10.4 weekly interval (52.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 220.5, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 395.7, "avg_administrations": 27}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,501
first_seen: 2022-09-25
last_seen: 2024-07-16
first_seen_parent: 2020-12-26
last_seen_parent: 2024-06-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 6.6 weekly interval (198.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 23 times with a 7.1 weekly interval (163.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 346.6, "avg_administrations": 11}, {"drug": "NIVOLUMAB", "avg_dose_mg": 329.9, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,582
first_seen: 2018-09-07
last_seen: 2025-07-19
first_seen_parent: 2020-11-25
last_seen_parent: 2024-05-17
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 142.6, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 11.9 weekly interval (130.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £20,966
first_seen: 2020-07-09
last_seen: 2024-07-05
first_seen_parent: 2020-12-10
last_seen_parent: 2025-09-12
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 233.9, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 25 times with a 9.5 weekly interval (237.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOCILIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,400
first_seen: 2020-04-12
last_seen: 2024-10-10
first_seen_parent: 2019-02-16
last_seen_parent: 2025-10-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 4.0 weekly interval (40.0 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 22 times with a 5.2 weekly interval (114.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 438.0, "avg_administrations": 25}, {"drug": "IBRUTINIB", "avg_dose_mg": 123.9, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £7,683
first_seen: 2019-06-18
last_seen: 2024-04-09
first_seen_parent: 2019-03-01
last_seen_parent: 2025-06-07
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 231.0, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 25 times with a 5.6 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,665
first_seen: 2018-05-02
last_seen: 2024-08-23
first_seen_parent: 2019-07-09
last_seen_parent: 2025-02-07
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 89.0, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 22 times with a 8.9 weekly interval (195.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,543
first_seen: 2021-06-12
last_seen: 2024-10-30
first_seen_parent: 2019-01-04
last_seen_parent: 2024-04-20
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 453.6, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 17 times with a 7.5 weekly interval (127.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,392
first_seen: 2020-03-25
last_seen: 2025-04-23
first_seen_parent: 2019-08-11
last_seen_parent: 2024-11-17
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 325.4, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11 times with a 7.5 weekly interval (82.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,328
first_seen: 2020-05-23
last_seen: 2025-02-25
first_seen_parent: 2018-05-13
last_seen_parent: 2025-12-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 8.2 weekly interval (229.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 7.1 weekly interval (35.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 404.3, "avg_administrations": 29}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 437.5, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,846
first_seen: 2022-01-29
last_seen: 2025-09-24
first_seen_parent: 2018-05-10
last_seen_parent: 2024-10-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 2.3 weekly interval (23.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 2.2 weekly interval (59.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 361.6, "avg_administrations": 6}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 430.3, "avg_administrations": 28}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,858
first_seen: 2018-10-22
last_seen: 2025-02-27
first_seen_parent: 2019-08-14
last_seen_parent: 2024-03-03
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 332.6, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 6.7 weekly interval (107.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,457
first_seen: 2019-02-19
last_seen: 2025-12-16
first_seen_parent: 2017-10-17
last_seen_parent: 2024-06-11
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 96.7, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 5.2 weekly interval (26.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £8,978
first_seen: 2019-06-07
last_seen: 2025-07-12
first_seen_parent: 2021-06-04
last_seen_parent: 2025-06-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 9.0 weekly interval (243.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 26 times with a 10.9 weekly interval (283.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 60.0, "avg_administrations": 22}, {"drug": "TOFACITINIB", "avg_dose_mg": 476.5, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £5,379
first_seen: 2021-07-11
last_seen: 2025-06-24
first_seen_parent: 2018-12-12
last_seen_parent: 2025-07-03
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 8.9 weekly interval (62.3 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 7 times with a 4.8 weekly interval (33.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 291.4, "avg_administrations": 27}, {"drug": "SECUKINUMAB", "avg_dose_mg": 473.3, "avg_administrations": 27}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,954
first_seen: 2018-03-09
last_seen: 2024-11-16
first_seen_parent: 2019-05-30
last_seen_parent: 2024-09-10
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 373.5, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 2.2 weekly interval (28.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,891
first_seen: 2020-12-01
last_seen: 2025-09-08
first_seen_parent: 2019-05-14
last_seen_parent: 2024-12-15
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 431.3, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 12 times with a 4.1 weekly interval (49.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,406
first_seen: 2020-02-23
last_seen: 2024-06-02
first_seen_parent: 2017-07-15
last_seen_parent: 2025-04-22
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 322.4, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 4 times with a 7.9 weekly interval (31.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,449
first_seen: 2019-02-17
last_seen: 2024-05-12
first_seen_parent: 2019-08-11
last_seen_parent: 2025-09-05
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 122.3, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 9.1 weekly interval (45.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £6,608
first_seen: 2020-06-11
last_seen: 2025-05-09
first_seen_parent: 2019-09-04
last_seen_parent: 2025-03-28
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 129.4, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 10.1 weekly interval (80.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,109
first_seen: 2019-08-05
last_seen: 2024-10-06
first_seen_parent: 2018-07-26
last_seen_parent: 2024-04-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 8.3 weekly interval (74.7 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 20 times with a 10.6 weekly interval (212.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 190.9, "avg_administrations": 20}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 450.3, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £26,458
first_seen: 2020-09-04
last_seen: 2025-11-06
first_seen_parent: 2020-11-08
last_seen_parent: 2024-12-19
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 153.3, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 16 times with a 11.2 weekly interval (179.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,746
first_seen: 2018-04-14
last_seen: 2024-07-30
first_seen_parent: 2017-04-29
last_seen_parent: 2025-01-29
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 486.3, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 5.5 weekly interval (82.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £15,649
first_seen: 2018-02-08
last_seen: 2024-11-06
first_seen_parent: 2017-12-19
last_seen_parent: 2025-10-16
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 117.4, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 14 times with a 7.1 weekly interval (99.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £20,946
first_seen: 2019-03-08
last_seen: 2025-01-27
first_seen_parent: 2019-05-13
last_seen_parent: 2024-01-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 7.8 weekly interval (132.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 302.5, "avg_administrations": 12}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 173.1, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £21,764
first_seen: 2019-06-02
last_seen: 2024-11-25
first_seen_parent: 2020-07-25
last_seen_parent: 2024-07-22
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 236.5, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 8.9 weekly interval (53.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,922
first_seen: 2020-07-26
last_seen: 2024-10-22
first_seen_parent: 2019-07-09
last_seen_parent: 2024-08-13
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 2.9 weekly interval (34.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 11.8 weekly interval (118.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 401.4, "avg_administrations": 10}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 133.0, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,069
first_seen: 2018-02-24
last_seen: 2024-12-04
first_seen_parent: 2019-11-01
last_seen_parent: 2025-10-08
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 210.5, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 24 times with a 10.2 weekly interval (244.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,918
first_seen: 2019-12-30
last_seen: 2025-04-28
first_seen_parent: 2018-08-23
last_seen_parent: 2024-06-05
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 439.7, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 10.7 weekly interval (42.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,877
first_seen: 2020-01-12
last_seen: 2024-07-15
first_seen_parent: 2020-08-03
last_seen_parent: 2024-09-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 5.3 weekly interval (42.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 30 times with a 2.0 weekly interval (60.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 410.8, "avg_administrations": 27}, {"drug": "SECUKINUMAB", "avg_dose_mg": 290.9, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £16,382
first_seen: 2020-12-08
last_seen: 2024-07-17
first_seen_parent: 2019-05-05
last_seen_parent: 2024-11-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 16 times with a 8.3 weekly interval (132.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 4.9 weekly interval (78.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 417.5, "avg_administrations": 27}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 268.3, "avg_administrations": 22}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £22,330
first_seen: 2020-04-03
last_seen: 2024-04-17
first_seen_parent: 2020-09-02
last_seen_parent: 2024-09-20
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 76.1, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 7 times with a 6.1 weekly interval (42.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £18,307
first_seen: 2018-06-12
last_seen: 2025-12-01
first_seen_parent: 2017-02-26
last_seen_parent: 2024-08-04
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 265.6, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,383
first_seen: 2019-01-01
last_seen: 2025-12-17
first_seen_parent: 2020-06-06
last_seen_parent: 2025-09-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 290.3, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 5.4 weekly interval (140.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,750
first_seen: 2019-07-13
last_seen: 2025-08-06
first_seen_parent: 2019-11-12
last_seen_parent: 2025-02-22
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 67.8, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 21 times with a 7.7 weekly interval (161.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,346
first_seen: 2018-10-25
last_seen: 2024-08-01
first_seen_parent: 2019-09-12
last_seen_parent: 2024-02-27
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 366.7, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 5.4 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £2,780
first_seen: 2022-08-31
last_seen: 2025-01-12
first_seen_parent: 2018-11-08
last_seen_parent: 2025-09-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 6.1 weekly interval (164.7 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 15 times with a 10.1 weekly interval (151.5 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 212.0, "avg_administrations": 7}, {"drug": "BARICITINIB", "avg_dose_mg": 267.2, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,059
first_seen: 2022-10-28
last_seen: 2025-05-28
first_seen_parent: 2021-03-03
last_seen_parent: 2024-05-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 7.0 weekly interval (189.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 29 times with a 5.2 weekly interval (150.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 336.9, "avg_administrations": 9}, {"drug": "ADALIMUMAB", "avg_dose_mg": 288.9, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,218
first_seen: 2021-06-13
last_seen: 2024-08-22
first_seen_parent: 2018-08-27
last_seen_parent: 2025-03-14
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 432.1, "avg_administrations": 13}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 11.1 weekly interval (222.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,653
first_seen: 2021-04-10
last_seen: 2025-04-19
first_seen_parent: 2018-07-19
last_seen_parent: 2025-11-06
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 316.0, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 4.1 weekly interval (32.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,356
first_seen: 2020-12-18
last_seen: 2025-05-10
first_seen_parent: 2017-10-14
last_seen_parent: 2024-12-03
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 171.1, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 7.1 weekly interval (156.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £28,986
first_seen: 2018-10-08
last_seen: 2024-10-11
first_seen_parent: 2019-05-01
last_seen_parent: 2024-01-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 345.3, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 10.6 weekly interval (137.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,302
first_seen: 2018-12-24
last_seen: 2024-02-07
first_seen_parent: 2017-10-24
last_seen_parent: 2025-02-01
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 412.2, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 2.6 weekly interval (59.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,261
first_seen: 2020-04-26
last_seen: 2025-08-17
first_seen_parent: 2020-12-25
last_seen_parent: 2024-11-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 5.8 weekly interval (168.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 15 times with a 10.5 weekly interval (157.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 168.1, "avg_administrations": 16}, {"drug": "TOFACITINIB", "avg_dose_mg": 321.2, "avg_administrations": 13}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,804
first_seen: 2019-06-15
last_seen: 2024-02-17
first_seen_parent: 2018-02-12
last_seen_parent: 2024-11-18
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 9.6 weekly interval (163.2 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 18 times with a 11.6 weekly interval (208.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 144.5, "avg_administrations": 10}, {"drug": "USTEKINUMAB", "avg_dose_mg": 423.1, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,194
first_seen: 2021-04-07
last_seen: 2024-04-25
first_seen_parent: 2017-11-06
last_seen_parent: 2025-08-21
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 226.7, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 4.6 weekly interval (50.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £12,230
first_seen: 2022-06-21
last_seen: 2024-09-26
first_seen_parent: 2019-04-16
last_seen_parent: 2025-12-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 9.6 weekly interval (230.4 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 19 times with a 2.1 weekly interval (39.9 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 474.9, "avg_administrations": 15}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 233.8, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,583
first_seen: 2019-11-27
last_seen: 2024-07-21
first_seen_parent: 2021-01-14
last_seen_parent: 2025-08-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 8.7 weekly interval (165.3 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 2.5 weekly interval (42.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 62.3, "avg_administrations": 18}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 64.0, "avg_administrations": 28}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,144
first_seen: 2018-09-29
last_seen: 2024-07-05
first_seen_parent: 2018-06-17
last_seen_parent: 2024-11-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 61.1, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6 times with a 11.0 weekly interval (66.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,831
first_seen: 2020-11-21
last_seen: 2025-09-07
first_seen_parent: 2017-06-22
last_seen_parent: 2025-04-29
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 343.9, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 8.4 weekly interval (142.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,810
first_seen: 2019-06-03
last_seen: 2024-05-08
first_seen_parent: 2020-02-18
last_seen_parent: 2024-10-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19 times with a 8.5 weekly interval (161.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 2.8 weekly interval (30.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 345.7, "avg_administrations": 25}, {"drug": "USTEKINUMAB", "avg_dose_mg": 499.7, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £6,851
first_seen: 2019-12-11
last_seen: 2024-11-18
first_seen_parent: 2017-03-23
last_seen_parent: 2025-12-23
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 207.2, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 28 times with a 11.8 weekly interval (330.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £15,554
first_seen: 2022-03-31
last_seen: 2025-02-22
first_seen_parent: 2020-04-05
last_seen_parent: 2024-03-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 11.4 weekly interval (114.0 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 5.8 weekly interval (92.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 55.4, "avg_administrations": 25}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 234.8, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,002
first_seen: 2020-09-25
last_seen: 2024-12-02
first_seen_parent: 2017-05-23
last_seen_parent: 2024-12-31
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 165.4, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 8.1 weekly interval (137.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,268
first_seen: 2020-05-03
last_seen: 2024-03-30
first_seen_parent: 2019-09-25
last_seen_parent: 2024-08-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 3.2 weekly interval (48.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 5.9 weekly interval (135.7 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 207.1, "avg_administrations": 7}, {"drug": "NATALIZUMAB", "avg_dose_mg": 170.2, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,081
first_seen: 2021-10-22
last_seen: 2025-03-18
first_seen_parent: 2019-02-24
last_seen_parent: 2025-02-18
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 8 times with a 2.3 weekly interval (18.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 6.4 weekly interval (51.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 211.5, "avg_administrations": 6}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 423.3, "avg_administrations": 24}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,060
first_seen: 2020-04-20
last_seen: 2024-12-28
first_seen_parent: 2019-02-12
last_seen_parent: 2025-05-23
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 107.8, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 7.7 weekly interval (146.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,707
first_seen: 2019-03-16
last_seen: 2025-08-12
first_seen_parent: 2018-11-04
last_seen_parent: 2024-03-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 11.4 weekly interval (114.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 19 times with a 2.3 weekly interval (43.7 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 345.2, "avg_administrations": 25}, {"drug": "NIVOLUMAB", "avg_dose_mg": 121.6, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,934
first_seen: 2021-05-16
last_seen: 2025-02-19
first_seen_parent: 2017-12-10
last_seen_parent: 2025-12-05
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 391.6, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 4.6 weekly interval (101.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £6,434
first_seen: 2018-10-01
last_seen: 2024-02-14
first_seen_parent: 2020-04-19
last_seen_parent: 2025-11-26
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 477.6, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 24 times with a 3.1 weekly interval (74.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £4,161
first_seen: 2022-12-22
last_seen: 2024-08-07
first_seen_parent: 2018-06-01
last_seen_parent: 2025-12-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 28 times with a 4.2 weekly interval (117.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 10 times with a 2.2 weekly interval (22.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 204.3, "avg_administrations": 5}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 81.2, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,126
first_seen: 2018-08-16
last_seen: 2024-05-17
first_seen_parent: 2018-09-17
last_seen_parent: 2024-01-25
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 141.7, "avg_administrations": 8}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 4.2 weekly interval (58.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,571
first_seen: 2020-04-25
last_seen: 2024-01-11
first_seen_parent: 2019-08-07
last_seen_parent: 2024-06-21
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 493.0, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 7.6 weekly interval (91.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,060
first_seen: 2022-10-09
last_seen: 2025-05-29
first_seen_parent: 2018-09-15
last_seen_parent: 2025-06-14
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 21 times with a 10.8 weekly interval (226.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 10 times with a 8.3 weekly interval (83.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 193.6, "avg_administrations": 29}, {"drug": "INFLIXIMAB", "avg_dose_mg": 299.5, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,840
first_seen: 2018-03-30
last_seen: 2025-09-05
first_seen_parent: 2017-11-25
last_seen_parent: 2025-07-11
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 457.4, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 5.6 weekly interval (84.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,821
first_seen: 2019-02-07
last_seen: 2025-08-11
first_seen_parent: 2019-07-20
last_seen_parent: 2024-05-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 11 times with a 9.9 weekly interval (108.9 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 9.9 weekly interval (267.3 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 125.1, "avg_administrations": 25}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 483.5, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £4,640
first_seen: 2021-09-20
last_seen: 2025-02-20
first_seen_parent: 2018-12-26
last_seen_parent: 2025-03-14
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 86.5, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 16 times with a 2.7 weekly interval (43.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,809
first_seen: 2021-07-13
last_seen: 2024-05-05
first_seen_parent: 2019-11-17
last_seen_parent: 2025-06-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 338.4, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 7.0 weekly interval (112.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £11,303
first_seen: 2020-03-26
last_seen: 2025-04-24
first_seen_parent: 2020-02-28
last_seen_parent: 2024-03-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 7.7 weekly interval (77.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 6.5 weekly interval (123.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 346.9, "avg_administrations": 29}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 350.3, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,336
first_seen: 2018-02-26
last_seen: 2024-05-13
first_seen_parent: 2017-07-28
last_seen_parent: 2025-02-27
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 91.8, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 21 times with a 9.6 weekly interval (201.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,131
first_seen: 2021-10-10
last_seen: 2024-03-07
first_seen_parent: 2017-10-23
last_seen_parent: 2025-10-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 153.7, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 12.0 weekly interval (312.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,156
first_seen: 2018-07-13
last_seen: 2024-11-09
first_seen_parent: 2018-06-13
last_seen_parent: 2024-12-27
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 460.9, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 12.0 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £28,107
first_seen: 2021-05-31
last_seen: 2024-12-02
first_seen_parent: 2017-12-10
last_seen_parent: 2025-11-22
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 450.4, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 12 times with a 10.6 weekly interval (127.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,082
first_seen: 2018-03-05
last_seen: 2024-12-30
first_seen_parent: 2017-01-12
last_seen_parent: 2025-06-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 70.6, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 2.5 weekly interval (72.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,537
first_seen: 2020-04-18
last_seen: 2024-02-09
first_seen_parent: 2020-02-03
last_seen_parent: 2024-01-30
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 88.9, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 26 times with a 6.5 weekly interval (169.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £20,972
first_seen: 2021-12-17
last_seen: 2025-02-11
first_seen_parent: 2018-05-20
last_seen_parent: 2024-02-22
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 328.6, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 28 times with a 6.8 weekly interval (190.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,093
first_seen: 2021-09-29
last_seen: 2025-06-30
first_seen_parent: 2019-09-24
last_seen_parent: 2025-11-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 10.3 weekly interval (92.7 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 16 times with a 11.9 weekly interval (190.4 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 408.7, "avg_administrations": 11}, {"drug": "NIVOLUMAB", "avg_dose_mg": 259.4, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,521
first_seen: 2020-11-18
last_seen: 2025-03-02
first_seen_parent: 2020-03-31
last_seen_parent: 2025-01-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 7.5 weekly interval (75.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 30 times with a 5.8 weekly interval (174.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 89.0, "avg_administrations": 24}, {"drug": "RITUXIMAB", "avg_dose_mg": 58.7, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,578
first_seen: 2018-02-18
last_seen: 2024-04-11
first_seen_parent: 2018-07-08
last_seen_parent: 2024-02-19
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 196.1, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 18 times with a 8.7 weekly interval (156.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,137
first_seen: 2019-11-16
last_seen: 2024-02-11
first_seen_parent: 2017-08-10
last_seen_parent: 2025-01-21
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 465.4, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 19 times with a 5.7 weekly interval (108.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £5,801
first_seen: 2020-03-14
last_seen: 2025-11-05
first_seen_parent: 2018-02-26
last_seen_parent: 2024-10-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 9.5 weekly interval (171.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 7 times with a 11.1 weekly interval (77.7 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 421.8, "avg_administrations": 7}, {"drug": "TOFACITINIB", "avg_dose_mg": 279.5, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £9,525
first_seen: 2021-01-19
last_seen: 2024-07-30
first_seen_parent: 2020-04-12
last_seen_parent: 2025-06-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 25 times with a 7.1 weekly interval (177.5 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 14 times with a 8.4 weekly interval (117.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 161.5, "avg_administrations": 16}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 377.8, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,462
first_seen: 2021-02-01
last_seen: 2024-08-07
first_seen_parent: 2019-11-06
last_seen_parent: 2025-01-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 415.2, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 7.5 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £5,641
first_seen: 2018-06-17
last_seen: 2024-10-18
first_seen_parent: 2018-09-05
last_seen_parent: 2025-02-01
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 275.1, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 24 times with a 7.5 weekly interval (180.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £11,481
first_seen: 2021-01-11
last_seen: 2024-12-21
first_seen_parent: 2021-06-13
last_seen_parent: 2025-03-04
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 30 times with a 9.8 weekly interval (294.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 5 times with a 9.3 weekly interval (46.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 388.8, "avg_administrations": 26}, {"drug": "INFLIXIMAB", "avg_dose_mg": 161.9, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,410
first_seen: 2020-03-26
last_seen: 2025-05-11
first_seen_parent: 2018-06-13
last_seen_parent: 2024-10-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 495.2, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 5 times with a 9.1 weekly interval (45.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,793
first_seen: 2020-03-16
last_seen: 2024-12-13
first_seen_parent: 2018-06-16
last_seen_parent: 2024-12-21
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 10.4 weekly interval (62.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 10.1 weekly interval (161.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 125.7, "avg_administrations": 29}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 352.1, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £13,084
first_seen: 2022-05-25
last_seen: 2025-06-11
first_seen_parent: 2019-08-26
last_seen_parent: 2024-01-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 3.9 weekly interval (31.2 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 6 times with a 4.3 weekly interval (25.8 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 65.4, "avg_administrations": 27}, {"drug": "BARICITINIB", "avg_dose_mg": 467.7, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,781
first_seen: 2019-04-15
last_seen: 2024-01-29
first_seen_parent: 2020-07-21
last_seen_parent: 2025-03-22
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 84.9, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 2.6 weekly interval (39.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,892
first_seen: 2019-11-21
last_seen: 2025-01-21
first_seen_parent: 2018-01-15
last_seen_parent: 2024-06-20
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 441.4, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 13 times with a 8.3 weekly interval (107.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,174
first_seen: 2018-08-30
last_seen: 2024-04-25
first_seen_parent: 2017-06-23
last_seen_parent: 2025-03-06
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 173.6, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 2.9 weekly interval (52.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £13,159
first_seen: 2022-01-19
last_seen: 2024-10-01
first_seen_parent: 2021-03-17
last_seen_parent: 2024-01-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 4.7 weekly interval (37.6 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 2.8 weekly interval (28.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 143.9, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 341.8, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,148
first_seen: 2022-12-21
last_seen: 2024-10-03
first_seen_parent: 2018-12-22
last_seen_parent: 2024-05-08
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 24 times with a 11.6 weekly interval (278.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 5 times with a 6.0 weekly interval (30.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 74.9, "avg_administrations": 12}, {"drug": "TOFACITINIB", "avg_dose_mg": 389.5, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,741
first_seen: 2019-06-13
last_seen: 2024-05-20
first_seen_parent: 2017-02-11
last_seen_parent: 2025-06-03
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 269.9, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 21 times with a 4.7 weekly interval (98.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,431
first_seen: 2018-03-20
last_seen: 2024-05-05
first_seen_parent: 2019-01-04
last_seen_parent: 2025-03-23
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 367.4, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 11.8 weekly interval (47.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,405
first_seen: 2021-07-06
last_seen: 2025-06-29
first_seen_parent: 2018-01-09
last_seen_parent: 2024-02-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 14 times with a 4.2 weekly interval (58.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 4.6 weekly interval (133.4 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 68.3, "avg_administrations": 24}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 392.8, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £15,138
first_seen: 2019-05-12
last_seen: 2024-01-30
first_seen_parent: 2020-01-14
last_seen_parent: 2024-08-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 3.6 weekly interval (32.4 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 3.4 weekly interval (13.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 119.9, "avg_administrations": 24}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 228.2, "avg_administrations": 22}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £17,026
first_seen: 2019-05-02
last_seen: 2024-07-12
first_seen_parent: 2017-11-07
last_seen_parent: 2025-11-29
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 471.0, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 20 times with a 6.9 weekly interval (138.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £21,326
first_seen: 2020-07-27
last_seen: 2025-06-30
first_seen_parent: 2021-05-27
last_seen_parent: 2024-10-15
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 25 times with a 3.0 weekly interval (75.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 24 times with a 4.4 weekly interval (105.6 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 93.7, "avg_administrations": 16}, {"drug": "INFLIXIMAB", "avg_dose_mg": 271.9, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £3,927
first_seen: 2020-12-23
last_seen: 2024-10-04
first_seen_parent: 2020-06-20
last_seen_parent: 2025-10-20
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 9.9 weekly interval (257.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 23 times with a 11.3 weekly interval (259.9 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 451.5, "avg_administrations": 26}, {"drug": "BARICITINIB", "avg_dose_mg": 499.2, "avg_administrations": 22}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,922
first_seen: 2021-01-07
last_seen: 2024-10-04
first_seen_parent: 2018-05-06
last_seen_parent: 2024-04-09
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 413.3, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 17 times with a 3.3 weekly interval (56.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £9,151
first_seen: 2020-12-27
last_seen: 2025-02-25
first_seen_parent: 2018-07-31
last_seen_parent: 2024-12-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 4 times with a 6.8 weekly interval (27.2 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 7.5 weekly interval (202.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 456.2, "avg_administrations": 27}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 82.9, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,470
first_seen: 2022-06-09
last_seen: 2025-05-14
first_seen_parent: 2018-10-27
last_seen_parent: 2025-11-17
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 16 times with a 7.2 weekly interval (115.2 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 7 times with a 10.6 weekly interval (74.2 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 135.5, "avg_administrations": 30}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 301.5, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,657
first_seen: 2019-06-24
last_seen: 2024-02-10
first_seen_parent: 2020-07-31
last_seen_parent: 2024-12-24
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 435.5, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 7.7 weekly interval (146.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,152
first_seen: 2020-09-28
last_seen: 2025-04-09
first_seen_parent: 2017-10-10
last_seen_parent: 2024-09-14
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 289.3, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 2.8 weekly interval (19.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £11,446
first_seen: 2019-11-02
last_seen: 2024-10-02
first_seen_parent: 2020-08-31
last_seen_parent: 2025-01-15
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 476.2, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 5.0 weekly interval (25.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £12,330
first_seen: 2020-05-25
last_seen: 2025-10-17
first_seen_parent: 2020-09-08
last_seen_parent: 2025-03-17
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 4.4 weekly interval (101.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 2.2 weekly interval (15.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 415.9, "avg_administrations": 6}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 389.6, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £11,316
first_seen: 2021-03-27
last_seen: 2025-08-23
first_seen_parent: 2021-06-24
last_seen_parent: 2025-05-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 10.8 weekly interval (97.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 6 times with a 7.9 weekly interval (47.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 81.2, "avg_administrations": 16}, {"drug": "IBRUTINIB", "avg_dose_mg": 301.4, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,944
first_seen: 2020-08-06
last_seen: 2024-12-12
first_seen_parent: 2020-08-28
last_seen_parent: 2024-11-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 185.1, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 2.1 weekly interval (50.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,552
first_seen: 2020-07-19
last_seen: 2025-06-17
first_seen_parent: 2017-03-03
last_seen_parent: 2025-06-29
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 152.1, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 5.7 weekly interval (153.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,222
first_seen: 2021-02-14
last_seen: 2025-02-09
first_seen_parent: 2021-04-26
last_seen_parent: 2025-01-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 9 times with a 5.9 weekly interval (53.1 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 13 times with a 5.3 weekly interval (68.9 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 210.9, "avg_administrations": 7}, {"drug": "IBRUTINIB", "avg_dose_mg": 218.1, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,884
first_seen: 2019-05-02
last_seen: 2024-02-23
first_seen_parent: 2020-10-24
last_seen_parent: 2025-01-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 2.3 weekly interval (43.7 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 6.6 weekly interval (46.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 177.5, "avg_administrations": 28}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 250.1, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,446
first_seen: 2019-06-12
last_seen: 2025-01-08
first_seen_parent: 2017-07-31
last_seen_parent: 2024-03-03
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 208.4, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 28 times with a 5.1 weekly interval (142.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,642
first_seen: 2021-09-27
last_seen: 2024-01-15
first_seen_parent: 2018-04-09
last_seen_parent: 2024-05-13
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 419.3, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 18 times with a 4.2 weekly interval (75.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £20,089
first_seen: 2019-12-24
last_seen: 2025-11-23
first_seen_parent: 2018-12-20
last_seen_parent: 2025-01-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 10.4 weekly interval (270.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 15 times with a 8.4 weekly interval (126.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 401.6, "avg_administrations": 16}, {"drug": "SECUKINUMAB", "avg_dose_mg": 397.5, "avg_administrations": 27}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £13,907
first_seen: 2021-10-10
last_seen: 2024-04-21
first_seen_parent: 2020-11-14
last_seen_parent: 2025-11-26
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 2.7 weekly interval (51.3 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 15 times with a 10.8 weekly interval (162.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 289.5, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 173.2, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,476
first_seen: 2022-04-02
last_seen: 2024-03-14
first_seen_parent: 2018-02-04
last_seen_parent: 2025-07-27
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11 times with a 11.9 weekly interval (130.9 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 20 times with a 8.9 weekly interval (178.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 194.1, "avg_administrations": 20}, {"drug": "USTEKINUMAB", "avg_dose_mg": 458.7, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,969
first_seen: 2019-12-16
last_seen: 2024-08-17
first_seen_parent: 2017-07-12
last_seen_parent: 2025-11-21
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 348.3, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 2.6 weekly interval (39.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £22,017
first_seen: 2019-12-11
last_seen: 2024-12-20
first_seen_parent: 2019-06-20
last_seen_parent: 2025-10-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 318.5, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 11.4 weekly interval (250.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,196
first_seen: 2019-08-05
last_seen: 2025-04-25
first_seen_parent: 2018-02-10
last_seen_parent: 2025-08-19
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 412.2, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6 times with a 8.7 weekly interval (52.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,718
first_seen: 2020-11-15
last_seen: 2024-06-10
first_seen_parent: 2019-06-07
last_seen_parent: 2025-09-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 387.9, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20 times with a 9.4 weekly interval (188.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £23,057
first_seen: 2018-07-18
last_seen: 2024-07-20
first_seen_parent: 2020-12-16
last_seen_parent: 2025-01-18
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 179.7, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 4.0 weekly interval (20.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,929
first_seen: 2019-07-01
last_seen: 2025-02-05
first_seen_parent: 2020-02-12
last_seen_parent: 2025-08-17
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 115.1, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 8.5 weekly interval (136.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £3,549
first_seen: 2021-04-01
last_seen: 2025-01-04
first_seen_parent: 2020-05-18
last_seen_parent: 2024-12-17
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 11.1 weekly interval (111.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 5.6 weekly interval (112.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 191.8, "avg_administrations": 23}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 56.6, "avg_administrations": 11}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,756
first_seen: 2019-11-14
last_seen: 2025-10-26
first_seen_parent: 2020-04-13
last_seen_parent: 2024-05-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 7 times with a 8.2 weekly interval (57.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 350.1, "avg_administrations": 20}, {"drug": "ADALIMUMAB", "avg_dose_mg": 324.5, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £22,667
first_seen: 2018-06-06
last_seen: 2024-11-22
first_seen_parent: 2018-08-29
last_seen_parent: 2024-05-23
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 370.7, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 9.2 weekly interval (36.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,492
first_seen: 2018-09-15
last_seen: 2024-04-23
first_seen_parent: 2019-10-01
last_seen_parent: 2025-07-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 339.6, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 19 times with a 3.7 weekly interval (70.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £20,167
first_seen: 2019-01-03
last_seen: 2025-03-12
first_seen_parent: 2019-06-24
last_seen_parent: 2025-09-10
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 423.9, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 7.4 weekly interval (29.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,754
first_seen: 2019-04-07
last_seen: 2025-01-22
first_seen_parent: 2020-09-23
last_seen_parent: 2025-04-08
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 475.0, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 14 times with a 7.8 weekly interval (109.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,336
first_seen: 2021-05-23
last_seen: 2024-02-19
first_seen_parent: 2020-04-29
last_seen_parent: 2024-03-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 8 times with a 8.2 weekly interval (65.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 25 times with a 7.2 weekly interval (180.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 462.8, "avg_administrations": 5}, {"drug": "NIVOLUMAB", "avg_dose_mg": 363.3, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,721
first_seen: 2019-02-19
last_seen: 2024-09-26
first_seen_parent: 2019-02-13
last_seen_parent: 2025-02-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 11.4 weekly interval (79.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 4.7 weekly interval (89.3 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 103.1, "avg_administrations": 6}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 392.1, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £14,032
first_seen: 2020-05-20
last_seen: 2024-03-12
first_seen_parent: 2020-07-30
last_seen_parent: 2024-02-13
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 206.4, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 3.3 weekly interval (89.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £18,972
first_seen: 2021-12-26
last_seen: 2025-04-15
first_seen_parent: 2018-08-03
last_seen_parent: 2025-12-04
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 234.5, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 27 times with a 3.0 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,480
first_seen: 2021-03-07
last_seen: 2025-09-17
first_seen_parent: 2019-02-08
last_seen_parent: 2025-12-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 13 times with a 11.2 weekly interval (145.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 2.9 weekly interval (84.1 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 364.3, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 323.0, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,531
first_seen: 2020-04-06
last_seen: 2024-05-09
first_seen_parent: 2018-07-29
last_seen_parent: 2024-05-13
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 26 times with a 5.1 weekly interval (132.6 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 7.6 weekly interval (174.8 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 311.2, "avg_administrations": 19}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 113.0, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £21,794
first_seen: 2018-07-10
last_seen: 2024-02-14
first_seen_parent: 2018-04-19
last_seen_parent: 2024-11-03
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 115.6, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 14 times with a 5.0 weekly interval (70.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - NIVOLUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,287
first_seen: 2022-10-19
last_seen: 2024-11-22
first_seen_parent: 2018-01-12
last_seen_parent: 2025-04-29
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 6.0 weekly interval (156.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 26 times with a 6.0 weekly interval (156.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 56.6, "avg_administrations": 30}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 330.5, "avg_administrations": 24}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,097
first_seen: 2018-03-28
last_seen: 2024-10-11
first_seen_parent: 2019-06-09
last_seen_parent: 2025-11-17
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 245.5, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 29 times with a 11.9 weekly interval (345.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,233
first_seen: 2021-03-08
last_seen: 2025-09-11
first_seen_parent: 2020-12-21
last_seen_parent: 2025-04-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 7 times with a 7.9 weekly interval (55.3 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 5.7 weekly interval (28.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 431.6, "avg_administrations": 28}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 432.6, "avg_administrations": 16}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,325
first_seen: 2019-11-30
last_seen: 2025-02-23
first_seen_parent: 2017-11-01
last_seen_parent: 2024-03-07
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 309.4, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 9.2 weekly interval (202.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,966
first_seen: 2018-02-18
last_seen: 2024-02-15
first_seen_parent: 2018-03-05
last_seen_parent: 2024-05-07
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 170.7, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 2.9 weekly interval (66.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £19,422
first_seen: 2019-04-11
last_seen: 2025-04-04
first_seen_parent: 2020-12-14
last_seen_parent: 2025-09-13
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 381.9, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 21 times with a 9.9 weekly interval (207.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,209
first_seen: 2019-02-18
last_seen: 2024-05-03
first_seen_parent: 2019-06-16
last_seen_parent: 2024-07-31
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 223.1, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 9.2 weekly interval (211.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,637
first_seen: 2019-05-02
last_seen: 2025-10-15
first_seen_parent: 2021-03-17
last_seen_parent: 2025-12-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 10.2 weekly interval (275.4 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 8.0 weekly interval (72.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 402.2, "avg_administrations": 5}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 416.9, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £19,577
first_seen: 2018-08-01
last_seen: 2024-09-08
first_seen_parent: 2018-02-25
last_seen_parent: 2024-01-13
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 191.4, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 11.1 weekly interval (111.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £19,251
first_seen: 2018-07-30
last_seen: 2024-06-29
first_seen_parent: 2020-12-01
last_seen_parent: 2025-04-18
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 389.8, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 6.5 weekly interval (136.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,154
first_seen: 2021-07-24
last_seen: 2025-12-27
first_seen_parent: 2019-07-26
last_seen_parent: 2024-05-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 10.8 weekly interval (183.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 12 times with a 10.3 weekly interval (123.6 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 130.1, "avg_administrations": 13}, {"drug": "NIVOLUMAB", "avg_dose_mg": 106.5, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,956
first_seen: 2022-12-22
last_seen: 2024-09-06
first_seen_parent: 2021-09-27
last_seen_parent: 2025-06-25
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 7.7 weekly interval (231.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 6 times with a 9.6 weekly interval (57.6 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 112.3, "avg_administrations": 30}, {"drug": "SECUKINUMAB", "avg_dose_mg": 409.2, "avg_administrations": 24}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £24,684
first_seen: 2019-12-15
last_seen: 2024-01-31
first_seen_parent: 2020-04-20
last_seen_parent: 2024-02-17
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 76.8, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 21 times with a 8.7 weekly interval (182.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,828
first_seen: 2022-01-29
last_seen: 2025-05-18
first_seen_parent: 2018-12-20
last_seen_parent: 2024-03-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 14 times with a 3.6 weekly interval (50.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 17 times with a 7.5 weekly interval (127.5 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 313.0, "avg_administrations": 22}, {"drug": "ADALIMUMAB", "avg_dose_mg": 284.2, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,275
first_seen: 2021-02-08
last_seen: 2024-03-01
first_seen_parent: 2018-07-22
last_seen_parent: 2024-10-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 25 times with a 8.1 weekly interval (202.5 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 16 times with a 5.8 weekly interval (92.8 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 477.3, "avg_administrations": 22}, {"drug": "RITUXIMAB", "avg_dose_mg": 125.5, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,543
first_seen: 2021-10-28
last_seen: 2025-11-12
first_seen_parent: 2017-06-19
last_seen_parent: 2024-12-12
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 404.5, "avg_administrations": 14}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 4 times with a 7.2 weekly interval (28.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,463
first_seen: 2021-06-06
last_seen: 2025-09-15
first_seen_parent: 2019-07-01
last_seen_parent: 2025-10-17
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 445.6, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 7.8 weekly interval (31.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,033
first_seen: 2020-08-08
last_seen: 2024-10-06
first_seen_parent: 2017-02-01
last_seen_parent: 2024-01-11
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 192.1, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 9.4 weekly interval (282.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: TOFACITINIB
cost_pp_pa: £19,046
first_seen: 2022-04-05
last_seen: 2024-12-16
first_seen_parent: 2021-07-01
last_seen_parent: 2024-05-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB - TOFACITINIB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 5.5 weekly interval (49.5 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 19 times with a 9.1 weekly interval (172.9 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 353.3, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 218.4, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £9,939
first_seen: 2020-12-01
last_seen: 2024-02-14
first_seen_parent: 2017-01-26
last_seen_parent: 2025-03-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 462.8, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 11.5 weekly interval (287.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,225
first_seen: 2021-09-25
last_seen: 2025-05-28
first_seen_parent: 2018-07-14
last_seen_parent: 2025-04-05
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 240.2, "avg_administrations": 16}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 13 times with a 3.6 weekly interval (46.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,696
first_seen: 2021-02-05
last_seen: 2024-03-20
first_seen_parent: 2018-03-06
last_seen_parent: 2024-02-01
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 5.8 weekly interval (127.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 19 times with a 9.6 weekly interval (182.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 305.7, "avg_administrations": 13}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 154.4, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £17,056
first_seen: 2019-07-26
last_seen: 2025-06-18
first_seen_parent: 2020-06-11
last_seen_parent: 2025-06-08
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 10.3 weekly interval (113.3 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 8.2 weekly interval (237.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 341.9, "avg_administrations": 9}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 382.2, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,394
first_seen: 2019-12-11
last_seen: 2025-02-24
first_seen_parent: 2018-03-21
last_seen_parent: 2024-05-01
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 281.7, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 10.4 weekly interval (93.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,712
first_seen: 2020-10-29
last_seen: 2025-05-24
first_seen_parent: 2020-08-04
last_seen_parent: 2024-03-26
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 91.7, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 9 times with a 5.1 weekly interval (45.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £23,064
first_seen: 2021-07-06
last_seen: 2024-04-04
first_seen_parent: 2019-04-14
last_seen_parent: 2024-09-24
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 146.0, "avg_administrations": 16}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 6.4 weekly interval (38.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,812
first_seen: 2021-01-09
last_seen: 2025-05-09
first_seen_parent: 2018-02-26
last_seen_parent: 2025-06-20
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 129.8, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,104
first_seen: 2020-04-15
last_seen: 2024-09-10
first_seen_parent: 2020-10-05
last_seen_parent: 2025-12-15
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 103.7, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 28 times with a 2.7 weekly interval (75.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,608
first_seen: 2021-12-14
last_seen: 2025-04-23
first_seen_parent: 2019-02-17
last_seen_parent: 2025-08-31
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 304.3, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 3.7 weekly interval (29.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £9,022
first_seen: 2020-09-07
last_seen: 2025-07-20
first_seen_parent: 2019-01-27
last_seen_parent: 2024-12-01
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 148.7, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 26 times with a 3.1 weekly interval (80.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,466
first_seen: 2018-08-11
last_seen: 2025-03-08
first_seen_parent: 2017-08-15
last_seen_parent: 2025-03-30
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 132.5, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 5.1 weekly interval (66.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,200
first_seen: 2019-02-10
last_seen: 2025-02-16
first_seen_parent: 2020-05-27
last_seen_parent: 2025-10-27
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 421.6, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 23 times with a 7.4 weekly interval (170.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,592
first_seen: 2018-07-16
last_seen: 2024-09-22
first_seen_parent: 2020-03-29
last_seen_parent: 2024-04-15
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 57.7, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 5 times with a 9.6 weekly interval (48.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,198
first_seen: 2020-04-20
last_seen: 2025-10-26
first_seen_parent: 2017-11-26
last_seen_parent: 2024-05-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 324.4, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 5.7 weekly interval (142.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,707
first_seen: 2022-10-25
last_seen: 2024-10-12
first_seen_parent: 2020-08-24
last_seen_parent: 2024-12-25
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 2.6 weekly interval (62.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 27 times with a 3.8 weekly interval (102.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 362.8, "avg_administrations": 15}, {"drug": "TOFACITINIB", "avg_dose_mg": 148.9, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £22,585
first_seen: 2021-04-04
last_seen: 2025-06-21
first_seen_parent: 2017-05-09
last_seen_parent: 2025-10-27
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 247.2, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 8.9 weekly interval (169.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,209
first_seen: 2020-02-17
last_seen: 2024-09-24
first_seen_parent: 2019-02-03
last_seen_parent: 2024-11-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 4 times with a 7.9 weekly interval (31.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 7.2 weekly interval (208.8 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 170.4, "avg_administrations": 29}, {"drug": "TOFACITINIB", "avg_dose_mg": 151.8, "avg_administrations": 4}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,989
first_seen: 2022-07-14
last_seen: 2025-12-16
first_seen_parent: 2021-12-04
last_seen_parent: 2024-11-04
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 6.8 weekly interval (88.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9 times with a 6.9 weekly interval (62.1 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 408.1, "avg_administrations": 11}, {"drug": "ADALIMUMAB", "avg_dose_mg": 472.3, "avg_administrations": 24}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,746
first_seen: 2021-02-01
last_seen: 2024-09-27
first_seen_parent: 2019-01-20
last_seen_parent: 2025-03-22
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 408.7, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 9.0 weekly interval (135.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £12,457
first_seen: 2018-03-22
last_seen: 2024-09-03
first_seen_parent: 2018-07-18
last_seen_parent: 2024-06-04
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 256.3, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 3.3 weekly interval (72.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,347
first_seen: 2022-04-25
last_seen: 2024-06-07
first_seen_parent: 2021-04-24
last_seen_parent: 2025-02-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 29 times with a 2.1 weekly interval (60.9 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 7 times with a 5.8 weekly interval (40.6 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 131.3, "avg_administrations": 14}, {"drug": "SECUKINUMAB", "avg_dose_mg": 276.6, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £10,686
first_seen: 2020-06-05
last_seen: 2024-08-30
first_seen_parent: 2020-09-22
last_seen_parent: 2024-11-09
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 171.6, "avg_administrations": 8}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 24 times with a 5.4 weekly interval (129.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £17,064
first_seen: 2020-01-01
last_seen: 2025-04-27
first_seen_parent: 2019-08-17
last_seen_parent: 2025-09-25
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 496.7, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 3.4 weekly interval (95.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: AFLIBERCEPT
cost_pp_pa: £3,454
first_seen: 2019-05-21
last_seen: 2024-07-04
first_seen_parent: 2018-12-27
last_seen_parent: 2024-05-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - AFLIBERCEPT

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 17 times with a 11.2 weekly interval (190.4 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 12 times with a 3.9 weekly interval (46.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 154.3, "avg_administrations": 6}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 211.1, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,586
first_seen: 2019-03-16
last_seen: 2025-11-04
first_seen_parent: 2018-03-11
last_seen_parent: 2025-04-15
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 251.5, "avg_administrations": 30}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 11.5 weekly interval (276.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £3,945
first_seen: 2018-07-12
last_seen: 2024-05-03
first_seen_parent: 2019-08-19
last_seen_parent: 2025-01-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 122.9, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 9 times with a 7.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,666
first_seen: 2018-01-30
last_seen: 2024-08-14
first_seen_parent: 2020-12-13
last_seen_parent: 2024-04-23
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 397.2, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 5.7 weekly interval (22.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,125
first_seen: 2018-10-11
last_seen: 2024-06-10
first_seen_parent: 2019-11-02
last_seen_parent: 2025-06-15
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 412.7, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 3.2 weekly interval (28.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £20,526
first_seen: 2021-01-15
last_seen: 2024-12-11
first_seen_parent: 2019-05-04
last_seen_parent: 2024-08-07
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 10.2 weekly interval (285.6 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 10 times with a 10.7 weekly interval (107.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 202.9, "avg_administrations": 10}, {"drug": "USTEKINUMAB", "avg_dose_mg": 289.9, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,043
first_seen: 2018-01-30
last_seen: 2025-07-28
first_seen_parent: 2019-12-24
last_seen_parent: 2025-03-06
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 431.8, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 8.7 weekly interval (243.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,475
first_seen: 2021-08-31
last_seen: 2024-12-13
first_seen_parent: 2021-01-28
last_seen_parent: 2024-05-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 7.8 weekly interval (101.4 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 16 times with a 11.2 weekly interval (179.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 457.9, "avg_administrations": 20}, {"drug": "SECUKINUMAB", "avg_dose_mg": 202.2, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,447
first_seen: 2021-06-06
last_seen: 2025-12-14
first_seen_parent: 2018-09-20
last_seen_parent: 2025-07-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 4.7 weekly interval (98.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 7.1 weekly interval (35.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 450.5, "avg_administrations": 18}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 460.9, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £10,560
first_seen: 2021-12-03
last_seen: 2025-06-07
first_seen_parent: 2019-02-24
last_seen_parent: 2024-06-18
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 215.9, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 7.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £19,285
first_seen: 2022-05-24
last_seen: 2024-05-04
first_seen_parent: 2019-09-02
last_seen_parent: 2024-02-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 20 times with a 4.3 weekly interval (86.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 249.4, "avg_administrations": 17}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 234.4, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £22,917
first_seen: 2018-12-18
last_seen: 2025-07-09
first_seen_parent: 2020-06-18
last_seen_parent: 2024-11-10
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 205.1, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 6 times with a 2.3 weekly interval (13.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £17,864
first_seen: 2020-03-28
last_seen: 2025-08-19
first_seen_parent: 2021-02-04
last_seen_parent: 2024-10-29
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 24 times with a 5.4 weekly interval (129.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 3.9 weekly interval (46.8 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 470.6, "avg_administrations": 19}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 490.6, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £21,544
first_seen: 2019-05-14
last_seen: 2025-01-23
first_seen_parent: 2020-03-28
last_seen_parent: 2024-12-14
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 325.6, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 17 times with a 4.6 weekly interval (78.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,530
first_seen: 2019-07-01
last_seen: 2025-09-17
first_seen_parent: 2019-08-10
last_seen_parent: 2024-02-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 411.9, "avg_administrations": 4}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 5 times with a 4.4 weekly interval (22.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,784
first_seen: 2020-01-03
last_seen: 2025-07-19
first_seen_parent: 2018-03-04
last_seen_parent: 2024-07-06
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 485.0, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 10 times with a 8.5 weekly interval (85.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,628
first_seen: 2018-06-15
last_seen: 2024-05-26
first_seen_parent: 2017-05-20
last_seen_parent: 2024-08-27
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 377.9, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 26 times with a 8.7 weekly interval (226.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,854
first_seen: 2021-11-04
last_seen: 2024-04-30
first_seen_parent: 2017-02-23
last_seen_parent: 2025-10-04
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 120.5, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16 times with a 5.7 weekly interval (91.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,079
first_seen: 2021-11-10
last_seen: 2024-07-05
first_seen_parent: 2020-08-19
last_seen_parent: 2025-08-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 4.2 weekly interval (21.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 24 times with a 4.3 weekly interval (103.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 76.3, "avg_administrations": 25}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 233.8, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,204
first_seen: 2021-05-25
last_seen: 2024-02-22
first_seen_parent: 2019-04-29
last_seen_parent: 2025-06-03
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 258.1, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 8.5 weekly interval (153.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,469
first_seen: 2022-05-04
last_seen: 2024-08-24
first_seen_parent: 2018-04-19
last_seen_parent: 2025-08-09
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 8.2 weekly interval (180.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 15 times with a 6.9 weekly interval (103.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 468.8, "avg_administrations": 20}, {"drug": "NATALIZUMAB", "avg_dose_mg": 424.1, "avg_administrations": 24}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £4,298
first_seen: 2022-08-23
last_seen: 2025-07-15
first_seen_parent: 2021-10-11
last_seen_parent: 2025-09-18
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 21 times with a 11.1 weekly interval (233.1 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 13 times with a 7.7 weekly interval (100.1 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 139.0, "avg_administrations": 4}, {"drug": "NIVOLUMAB", "avg_dose_mg": 468.5, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,518
first_seen: 2019-05-27
last_seen: 2024-02-27
first_seen_parent: 2017-05-28
last_seen_parent: 2025-10-12
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 375.9, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 11 times with a 7.8 weekly interval (85.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,371
first_seen: 2018-03-20
last_seen: 2024-04-09
first_seen_parent: 2018-02-21
last_seen_parent: 2024-05-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 455.7, "avg_administrations": 10}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 9.8 weekly interval (137.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,909
first_seen: 2020-07-31
last_seen: 2025-03-15
first_seen_parent: 2018-05-07
last_seen_parent: 2024-01-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24 times with a 3.0 weekly interval (72.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 19 times with a 9.7 weekly interval (184.3 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 171.9, "avg_administrations": 6}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 182.0, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,335
first_seen: 2022-09-22
last_seen: 2024-10-14
first_seen_parent: 2018-04-24
last_seen_parent: 2024-05-06
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 8.0 weekly interval (232.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 28 times with a 2.3 weekly interval (64.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 343.6, "avg_administrations": 17}, {"drug": "NIVOLUMAB", "avg_dose_mg": 348.2, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,931
first_seen: 2018-03-29
last_seen: 2024-05-19
first_seen_parent: 2020-06-02
last_seen_parent: 2024-09-29
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 298.8, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 9.4 weekly interval (206.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £12,842
first_seen: 2019-04-01
last_seen: 2025-11-14
first_seen_parent: 2020-06-12
last_seen_parent: 2024-04-10
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 468.5, "avg_administrations": 26}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 4.3 weekly interval (25.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,160
first_seen: 2020-11-24
last_seen: 2025-06-07
first_seen_parent: 2019-08-21
last_seen_parent: 2024-12-30
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 5 times with a 4.6 weekly interval (23.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 28 times with a 9.5 weekly interval (266.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 324.6, "avg_administrations": 14}, {"drug": "NIVOLUMAB", "avg_dose_mg": 223.4, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,951
first_seen: 2019-12-20
last_seen: 2024-06-13
first_seen_parent: 2021-10-14
last_seen_parent: 2024-02-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 9.6 weekly interval (172.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 3.7 weekly interval (29.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 279.4, "avg_administrations": 9}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 74.4, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,110
first_seen: 2020-01-19
last_seen: 2025-07-25
first_seen_parent: 2018-02-12
last_seen_parent: 2024-12-11
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 328.2, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 9.0 weekly interval (270.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,138
first_seen: 2022-12-21
last_seen: 2024-08-19
first_seen_parent: 2019-04-13
last_seen_parent: 2025-07-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 21 times with a 8.4 weekly interval (176.4 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 5 times with a 5.6 weekly interval (28.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 368.6, "avg_administrations": 15}, {"drug": "NIVOLUMAB", "avg_dose_mg": 319.0, "avg_administrations": 27}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £22,571
first_seen: 2021-02-16
last_seen: 2024-09-03
first_seen_parent: 2017-08-29
last_seen_parent: 2025-02-28
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 199.7, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 8 times with a 11.4 weekly interval (91.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £7,277
first_seen: 2020-11-14
last_seen: 2025-07-15
first_seen_parent: 2021-12-21
last_seen_parent: 2024-11-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 8.3 weekly interval (91.3 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 9 times with a 8.7 weekly interval (78.3 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 293.6, "avg_administrations": 5}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 287.7, "avg_administrations": 16}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,847
first_seen: 2019-05-02
last_seen: 2025-03-31
first_seen_parent: 2020-09-27
last_seen_parent: 2025-02-21
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 62.9, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 11.6 weekly interval (69.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,743
first_seen: 2019-04-21
last_seen: 2024-09-03
first_seen_parent: 2018-09-29
last_seen_parent: 2025-02-07
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 17 times with a 10.1 weekly interval (171.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 28 times with a 5.8 weekly interval (162.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 420.8, "avg_administrations": 27}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 494.8, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,267
first_seen: 2022-08-25
last_seen: 2024-06-15
first_seen_parent: 2019-07-02
last_seen_parent: 2024-03-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 5.7 weekly interval (131.1 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 4.0 weekly interval (68.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 171.4, "avg_administrations": 12}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 408.2, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £18,048
first_seen: 2021-02-23
last_seen: 2024-09-15
first_seen_parent: 2018-02-24
last_seen_parent: 2025-11-15
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 417.7, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 4.2 weekly interval (21.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,926
first_seen: 2021-01-18
last_seen: 2025-01-22
first_seen_parent: 2020-08-21
last_seen_parent: 2024-09-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 11 times with a 8.1 weekly interval (89.1 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 11.7 weekly interval (140.4 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 323.1, "avg_administrations": 10}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 395.9, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £26,090
first_seen: 2020-11-09
last_seen: 2024-10-14
first_seen_parent: 2019-06-19
last_seen_parent: 2024-11-23
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 350.7, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 9 times with a 8.4 weekly interval (75.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £8,108
first_seen: 2019-02-26
last_seen: 2024-07-31
first_seen_parent: 2018-04-17
last_seen_parent: 2024-06-26
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18 times with a 2.3 weekly interval (41.4 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 6 times with a 2.5 weekly interval (15.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 470.2, "avg_administrations": 12}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 353.9, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £21,971
first_seen: 2021-12-28
last_seen: 2025-06-21
first_seen_parent: 2017-05-20
last_seen_parent: 2024-10-25
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 58.1, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 26 times with a 7.8 weekly interval (202.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £23,060
first_seen: 2021-02-02
last_seen: 2025-02-24
first_seen_parent: 2017-05-24
last_seen_parent: 2024-07-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 185.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 5.7 weekly interval (119.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,682
first_seen: 2020-02-04
last_seen: 2025-09-26
first_seen_parent: 2019-11-13
last_seen_parent: 2024-08-11
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 405.7, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 3.2 weekly interval (35.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,416
first_seen: 2022-03-31
last_seen: 2025-08-08
first_seen_parent: 2018-04-08
last_seen_parent: 2024-05-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 10.2 weekly interval (91.8 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 6.0 weekly interval (30.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 366.6, "avg_administrations": 25}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 159.2, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,951
first_seen: 2019-09-16
last_seen: 2025-02-16
first_seen_parent: 2019-06-24
last_seen_parent: 2025-04-25
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 403.6, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 25 times with a 5.4 weekly interval (135.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £27,050
first_seen: 2018-01-11
last_seen: 2024-09-04
first_seen_parent: 2018-02-05
last_seen_parent: 2025-01-20
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 222.7, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 7.2 weekly interval (72.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,653
first_seen: 2021-06-18
last_seen: 2024-12-16
first_seen_parent: 2020-01-19
last_seen_parent: 2024-11-25
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 232.3, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 9.8 weekly interval (117.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,264
first_seen: 2020-08-06
last_seen: 2025-02-16
first_seen_parent: 2020-05-16
last_seen_parent: 2025-07-29
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 26 times with a 5.4 weekly interval (140.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 30 times with a 9.8 weekly interval (294.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 477.4, "avg_administrations": 9}, {"drug": "NATALIZUMAB", "avg_dose_mg": 374.6, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,506
first_seen: 2022-02-20
last_seen: 2025-08-09
first_seen_parent: 2020-10-19
last_seen_parent: 2025-04-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 27 times with a 8.3 weekly interval (224.1 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 338.7, "avg_administrations": 20}, {"drug": "TOFACITINIB", "avg_dose_mg": 309.5, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,817
first_seen: 2021-02-06
last_seen: 2025-08-14
first_seen_parent: 2018-03-09
last_seen_parent: 2024-10-13
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 434.0, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 2.1 weekly interval (46.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,367
first_seen: 2018-03-18
last_seen: 2024-01-01
first_seen_parent: 2018-12-01
last_seen_parent: 2024-03-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 349.6, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 27 times with a 10.2 weekly interval (275.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,871
first_seen: 2022-11-25
last_seen: 2024-10-15
first_seen_parent: 2018-07-26
last_seen_parent: 2025-12-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 8.8 weekly interval (79.2 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 8 times with a 11.7 weekly interval (93.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 89.8, "avg_administrations": 28}, {"drug": "RITUXIMAB", "avg_dose_mg": 489.0, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,189
first_seen: 2022-05-23
last_seen: 2025-01-14
first_seen_parent: 2018-10-13
last_seen_parent: 2024-11-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 2.9 weekly interval (40.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 28 times with a 7.0 weekly interval (196.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 208.9, "avg_administrations": 16}, {"drug": "INFLIXIMAB", "avg_dose_mg": 338.8, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,172
first_seen: 2018-01-20
last_seen: 2025-02-07
first_seen_parent: 2017-10-16
last_seen_parent: 2024-06-11
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 420.1, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 9.1 weekly interval (91.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,759
first_seen: 2019-08-28
last_seen: 2025-10-18
first_seen_parent: 2020-10-14
last_seen_parent: 2025-12-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 19 times with a 2.4 weekly interval (45.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 11.5 weekly interval (138.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 361.8, "avg_administrations": 21}, {"drug": "TOFACITINIB", "avg_dose_mg": 391.0, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £18,011
first_seen: 2020-07-09
last_seen: 2025-09-11
first_seen_parent: 2017-01-22
last_seen_parent: 2025-07-19
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 278.4, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 3.2 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,820
first_seen: 2021-05-18
last_seen: 2025-03-06
first_seen_parent: 2020-02-29
last_seen_parent: 2025-08-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 21 times with a 2.5 weekly interval (52.5 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 25 times with a 6.3 weekly interval (157.5 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 383.0, "avg_administrations": 26}, {"drug": "ADALIMUMAB", "avg_dose_mg": 291.0, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £18,335
first_seen: 2020-08-07
last_seen: 2025-05-03
first_seen_parent: 2017-11-16
last_seen_parent: 2024-10-21
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 458.6, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 3.4 weekly interval (44.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £22,087
first_seen: 2018-12-30
last_seen: 2025-03-14
first_seen_parent: 2018-04-05
last_seen_parent: 2025-10-22
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 264.5, "avg_administrations": 27}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 6 times with a 11.1 weekly interval (66.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £7,174
first_seen: 2020-08-30
last_seen: 2025-10-15
first_seen_parent: 2018-03-19
last_seen_parent: 2024-07-10
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 144.4, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 5.2 weekly interval (156.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,791
first_seen: 2019-03-27
last_seen: 2025-09-13
first_seen_parent: 2017-11-18
last_seen_parent: 2025-06-11
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 165.2, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 2.4 weekly interval (28.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,893
first_seen: 2020-05-07
last_seen: 2025-02-05
first_seen_parent: 2017-08-27
last_seen_parent: 2025-09-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 137.6, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 20 times with a 11.5 weekly interval (230.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: ETANERCEPT
cost_pp_pa: £11,048
first_seen: 2022-02-02
last_seen: 2025-05-14
first_seen_parent: 2019-09-02
last_seen_parent: 2025-05-28
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - ETANERCEPT

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 6.5 weekly interval (104.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 12 times with a 3.6 weekly interval (43.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 292.3, "avg_administrations": 6}, {"drug": "ETANERCEPT", "avg_dose_mg": 244.6, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £8,585
first_seen: 2018-09-17
last_seen: 2024-01-11
first_seen_parent: 2018-12-27
last_seen_parent: 2024-11-22
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 98.0, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 8.3 weekly interval (141.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,538
first_seen: 2020-11-27
last_seen: 2025-04-15
first_seen_parent: 2017-10-23
last_seen_parent: 2025-03-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 100.5, "avg_administrations": 9}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 8 times with a 8.9 weekly interval (71.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,238
first_seen: 2019-07-01
last_seen: 2024-02-28
first_seen_parent: 2018-07-04
last_seen_parent: 2024-11-22
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 214.3, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 6.9 weekly interval (110.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,758
first_seen: 2019-09-14
last_seen: 2025-07-07
first_seen_parent: 2020-09-20
last_seen_parent: 2025-12-06
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 29 times with a 8.3 weekly interval (240.7 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 10.3 weekly interval (298.7 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 90.2, "avg_administrations": 21}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 231.3, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £20,730
first_seen: 2019-06-07
last_seen: 2025-07-27
first_seen_parent: 2019-07-12
last_seen_parent: 2025-06-26
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 79.3, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 27 times with a 4.2 weekly interval (113.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £15,362
first_seen: 2021-05-06
last_seen: 2024-03-29
first_seen_parent: 2021-04-29
last_seen_parent: 2025-01-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20 times with a 4.1 weekly interval (82.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 11.4 weekly interval (307.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 211.6, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 496.1, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,975
first_seen: 2018-02-03
last_seen: 2024-12-05
first_seen_parent: 2017-12-17
last_seen_parent: 2024-02-28
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 354.9, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 4.3 weekly interval (124.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,908
first_seen: 2022-04-21
last_seen: 2024-08-18
first_seen_parent: 2019-07-08
last_seen_parent: 2025-06-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 24 times with a 7.9 weekly interval (189.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 9 times with a 8.9 weekly interval (80.1 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 469.8, "avg_administrations": 15}, {"drug": "ETANERCEPT", "avg_dose_mg": 290.6, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,306
first_seen: 2019-02-13
last_seen: 2025-04-14
first_seen_parent: 2018-07-03
last_seen_parent: 2025-03-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 136.6, "avg_administrations": 26}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 10.3 weekly interval (123.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,130
first_seen: 2021-10-10
last_seen: 2025-11-18
first_seen_parent: 2020-04-14
last_seen_parent: 2024-06-07
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 294.2, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 7.0 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £11,073
first_seen: 2020-03-01
last_seen: 2025-02-11
first_seen_parent: 2021-05-14
last_seen_parent: 2025-12-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 5.3 weekly interval (90.1 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 2.5 weekly interval (57.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 384.0, "avg_administrations": 27}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 424.9, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £3,251
first_seen: 2019-11-16
last_seen: 2024-05-25
first_seen_parent: 2021-08-14
last_seen_parent: 2025-02-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 22 times with a 2.8 weekly interval (61.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 8 times with a 4.2 weekly interval (33.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 93.0, "avg_administrations": 13}, {"drug": "INFLIXIMAB", "avg_dose_mg": 378.4, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,821
first_seen: 2020-04-04
last_seen: 2025-03-03
first_seen_parent: 2018-03-27
last_seen_parent: 2025-09-22
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 376.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 13 times with a 7.8 weekly interval (101.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £13,159
first_seen: 2021-11-10
last_seen: 2024-08-27
first_seen_parent: 2019-06-17
last_seen_parent: 2024-06-20
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 16 times with a 6.7 weekly interval (107.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 4 times with a 3.5 weekly interval (14.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 209.3, "avg_administrations": 7}, {"drug": "INFLIXIMAB", "avg_dose_mg": 297.6, "avg_administrations": 16}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £2,697
first_seen: 2022-12-23
last_seen: 2025-09-12
first_seen_parent: 2019-10-14
last_seen_parent: 2024-01-04
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 7 times with a 3.7 weekly interval (25.9 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 26 times with a 11.0 weekly interval (286.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 246.1, "avg_administrations": 15}, {"drug": "TOFACITINIB", "avg_dose_mg": 428.3, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £19,648
first_seen: 2021-07-23
last_seen: 2024-12-01
first_seen_parent: 2020-12-24
last_seen_parent: 2024-06-03
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 335.2, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 11.5 weekly interval (333.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £4,064
first_seen: 2022-11-30
last_seen: 2025-11-01
first_seen_parent: 2021-12-27
last_seen_parent: 2024-05-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 11.3 weekly interval (56.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 26 times with a 5.5 weekly interval (143.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 474.0, "avg_administrations": 8}, {"drug": "SECUKINUMAB", "avg_dose_mg": 280.7, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,670
first_seen: 2021-06-16
last_seen: 2024-05-24
first_seen_parent: 2021-12-03
last_seen_parent: 2025-06-12
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 7.7 weekly interval (223.3 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 11 times with a 8.0 weekly interval (88.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 389.1, "avg_administrations": 23}, {"drug": "USTEKINUMAB", "avg_dose_mg": 148.8, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,676
first_seen: 2021-11-01
last_seen: 2024-09-14
first_seen_parent: 2017-03-28
last_seen_parent: 2024-01-29
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 245.5, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 10.2 weekly interval (91.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £17,037
first_seen: 2020-03-12
last_seen: 2025-04-30
first_seen_parent: 2017-09-19
last_seen_parent: 2024-07-18
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 201.7, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 26 times with a 8.4 weekly interval (218.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,725
first_seen: 2020-02-18
last_seen: 2024-01-21
first_seen_parent: 2019-02-28
last_seen_parent: 2025-07-06
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 420.8, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 4.9 weekly interval (132.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £25,068
first_seen: 2020-02-05
last_seen: 2024-07-09
first_seen_parent: 2020-10-02
last_seen_parent: 2024-12-27
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 276.0, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 27 times with a 2.9 weekly interval (78.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £21,971
first_seen: 2021-09-22
last_seen: 2025-03-16
first_seen_parent: 2017-12-25
last_seen_parent: 2024-05-17
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 319.6, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 2.6 weekly interval (44.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £3,530
first_seen: 2018-02-10
last_seen: 2025-12-09
first_seen_parent: 2018-07-09
last_seen_parent: 2025-05-08
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 168.4, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 11.6 weekly interval (185.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £23,787
first_seen: 2019-07-24
last_seen: 2024-05-04
first_seen_parent: 2019-03-06
last_seen_parent: 2025-07-14
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 466.5, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 3.5 weekly interval (56.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £26,100
first_seen: 2019-10-18
last_seen: 2024-04-06
first_seen_parent: 2020-10-02
last_seen_parent: 2024-05-08
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 203.4, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 11.8 weekly interval (342.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,532
first_seen: 2022-04-03
last_seen: 2024-09-24
first_seen_parent: 2020-08-04
last_seen_parent: 2025-01-10
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 3.1 weekly interval (65.1 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 4 times with a 11.1 weekly interval (44.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 208.5, "avg_administrations": 12}, {"drug": "IBRUTINIB", "avg_dose_mg": 167.3, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £7,196
first_seen: 2020-03-12
last_seen: 2025-08-28
first_seen_parent: 2021-06-15
last_seen_parent: 2025-09-30
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 2.7 weekly interval (78.3 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 10.7 weekly interval (64.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 486.6, "avg_administrations": 28}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 409.4, "avg_administrations": 11}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £25,243
first_seen: 2020-12-25
last_seen: 2025-10-28
first_seen_parent: 2017-07-07
last_seen_parent: 2024-04-16
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 239.8, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 10.0 weekly interval (110.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £4,297
first_seen: 2019-12-23
last_seen: 2024-08-19
first_seen_parent: 2018-02-10
last_seen_parent: 2025-08-18
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 50.9, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 4.3 weekly interval (73.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £15,575
first_seen: 2019-08-12
last_seen: 2024-05-03
first_seen_parent: 2019-03-07
last_seen_parent: 2025-03-18
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 231.7, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 2.8 weekly interval (72.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £20,254
first_seen: 2019-12-02
last_seen: 2025-06-22
first_seen_parent: 2020-11-30
last_seen_parent: 2024-01-18
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 192.9, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 4 times with a 11.5 weekly interval (46.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,842
first_seen: 2019-12-13
last_seen: 2024-08-28
first_seen_parent: 2019-08-18
last_seen_parent: 2025-02-07
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 176.7, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 8.4 weekly interval (193.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,704
first_seen: 2021-01-18
last_seen: 2025-05-12
first_seen_parent: 2020-03-27
last_seen_parent: 2024-02-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 13 times with a 2.1 weekly interval (27.3 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 322.4, "avg_administrations": 22}, {"drug": "NIVOLUMAB", "avg_dose_mg": 65.2, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £16,747
first_seen: 2021-09-18
last_seen: 2025-10-03
first_seen_parent: 2021-05-06
last_seen_parent: 2024-05-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 7.9 weekly interval (79.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 16 times with a 2.3 weekly interval (36.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 475.8, "avg_administrations": 8}, {"drug": "RITUXIMAB", "avg_dose_mg": 499.4, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,726
first_seen: 2018-12-19
last_seen: 2025-09-20
first_seen_parent: 2020-02-27
last_seen_parent: 2025-09-21
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 457.6, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 7.9 weekly interval (79.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,082
first_seen: 2022-01-24
last_seen: 2025-05-15
first_seen_parent: 2020-10-16
last_seen_parent: 2024-12-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 2.7 weekly interval (40.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 4 times with a 7.1 weekly interval (28.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 485.6, "avg_administrations": 30}, {"drug": "NIVOLUMAB", "avg_dose_mg": 227.4, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £12,657
first_seen: 2019-10-23
last_seen: 2025-02-20
first_seen_parent: 2020-01-28
last_seen_parent: 2024-01-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 2.6 weekly interval (52.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 8 times with a 7.8 weekly interval (62.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 70.7, "avg_administrations": 8}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 390.2, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,876
first_seen: 2019-05-11
last_seen: 2024-08-11
first_seen_parent: 2018-10-10
last_seen_parent: 2024-08-19
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 148.6, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 4.9 weekly interval (53.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £20,529
first_seen: 2020-08-17
last_seen: 2025-10-30
first_seen_parent: 2017-10-25
last_seen_parent: 2024-02-24
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 158.7, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 10.1 weekly interval (212.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £15,030
first_seen: 2019-01-10
last_seen: 2024-09-16
first_seen_parent: 2020-11-07
last_seen_parent: 2024-09-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 6 times with a 9.8 weekly interval (58.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 4.9 weekly interval (39.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 245.9, "avg_administrations": 13}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 120.9, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £13,283
first_seen: 2020-10-27
last_seen: 2024-10-29
first_seen_parent: 2021-02-08
last_seen_parent: 2024-12-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 9.9 weekly interval (237.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 19 times with a 10.4 weekly interval (197.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 60.4, "avg_administrations": 20}, {"drug": "ETANERCEPT", "avg_dose_mg": 403.5, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £20,790
first_seen: 2021-10-22
last_seen: 2025-12-23
first_seen_parent: 2019-10-11
last_seen_parent: 2024-03-31
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 232.9, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 14 times with a 9.1 weekly interval (127.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,976
first_seen: 2021-04-04
last_seen: 2025-02-22
first_seen_parent: 2018-01-22
last_seen_parent: 2024-10-31
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 371.9, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 7.8 weekly interval (46.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £20,229
first_seen: 2019-08-09
last_seen: 2025-09-11
first_seen_parent: 2018-04-21
last_seen_parent: 2024-09-25
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 345.0, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 14 times with a 8.2 weekly interval (114.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,587
first_seen: 2022-05-29
last_seen: 2024-05-10
first_seen_parent: 2019-06-06
last_seen_parent: 2024-03-28
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 13 times with a 9.3 weekly interval (120.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 6 times with a 4.0 weekly interval (24.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 184.8, "avg_administrations": 28}, {"drug": "NIVOLUMAB", "avg_dose_mg": 337.5, "avg_administrations": 16}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,264
first_seen: 2022-06-26
last_seen: 2025-07-24
first_seen_parent: 2021-12-11
last_seen_parent: 2024-01-30
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 8.8 weekly interval (35.2 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 11 times with a 9.8 weekly interval (107.8 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 473.7, "avg_administrations": 23}, {"drug": "TOFACITINIB", "avg_dose_mg": 67.1, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,764
first_seen: 2021-01-03
last_seen: 2024-10-04
first_seen_parent: 2019-08-25
last_seen_parent: 2025-01-12
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 198.9, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 13 times with a 3.8 weekly interval (49.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,645
first_seen: 2020-12-20
last_seen: 2024-09-08
first_seen_parent: 2019-07-27
last_seen_parent: 2025-05-06
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 80.9, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 13 times with a 4.0 weekly interval (52.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,871
first_seen: 2019-10-28
last_seen: 2024-07-14
first_seen_parent: 2017-09-24
last_seen_parent: 2024-08-18
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 434.0, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 26 times with a 10.5 weekly interval (273.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,296
first_seen: 2019-03-14
last_seen: 2024-12-12
first_seen_parent: 2018-05-23
last_seen_parent: 2025-12-15
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 417.2, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 6.9 weekly interval (34.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,737
first_seen: 2019-10-26
last_seen: 2025-05-08
first_seen_parent: 2020-09-07
last_seen_parent: 2024-03-15
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 274.3, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 7.5 weekly interval (30.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £13,313
first_seen: 2022-09-01
last_seen: 2024-09-16
first_seen_parent: 2021-04-14
last_seen_parent: 2024-07-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 6.8 weekly interval (122.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 6.4 weekly interval (70.4 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 398.7, "avg_administrations": 28}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 294.5, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £10,301
first_seen: 2020-09-14
last_seen: 2025-03-17
first_seen_parent: 2018-11-27
last_seen_parent: 2024-04-18
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 489.8, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 21 times with a 8.7 weekly interval (182.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,680
first_seen: 2018-01-02
last_seen: 2025-08-25
first_seen_parent: 2019-10-16
last_seen_parent: 2024-04-10
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 458.1, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 9.0 weekly interval (252.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £20,091
first_seen: 2018-10-07
last_seen: 2025-08-18
first_seen_parent: 2019-05-22
last_seen_parent: 2025-09-24
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 462.8, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 24 times with a 3.2 weekly interval (76.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £4,836
first_seen: 2020-03-10
last_seen: 2025-11-17
first_seen_parent: 2018-01-06
last_seen_parent: 2024-03-27
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 8.9 weekly interval (169.1 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 24 times with a 4.9 weekly interval (117.6 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 494.4, "avg_administrations": 20}, {"drug": "INFLIXIMAB", "avg_dose_mg": 55.8, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £3,917
first_seen: 2019-11-01
last_seen: 2024-12-17
first_seen_parent: 2021-11-13
last_seen_parent: 2025-05-29
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 15 times with a 8.1 weekly interval (121.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 17 times with a 6.0 weekly interval (102.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 236.2, "avg_administrations": 26}, {"drug": "USTEKINUMAB", "avg_dose_mg": 229.9, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,829
first_seen: 2019-04-12
last_seen: 2024-03-15
first_seen_parent: 2020-06-02
last_seen_parent: 2024-11-18
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 142.4, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 6.1 weekly interval (152.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,041
first_seen: 2021-02-25
last_seen: 2025-08-10
first_seen_parent: 2020-07-10
last_seen_parent: 2024-03-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 6.3 weekly interval (100.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 25 times with a 7.5 weekly interval (187.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 455.8, "avg_administrations": 6}, {"drug": "RITUXIMAB", "avg_dose_mg": 274.5, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £18,673
first_seen: 2020-08-15
last_seen: 2025-01-30
first_seen_parent: 2020-12-11
last_seen_parent: 2024-06-30
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - OCRELIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 2.6 weekly interval (31.2 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 3.3 weekly interval (49.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 428.1, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 174.8, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,431
first_seen: 2020-09-18
last_seen: 2024-04-09
first_seen_parent: 2020-04-22
last_seen_parent: 2025-04-23
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 168.7, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 5 times with a 3.9 weekly interval (19.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,460
first_seen: 2020-03-20
last_seen: 2024-05-20
first_seen_parent: 2020-03-18
last_seen_parent: 2024-07-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 10.7 weekly interval (224.7 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 30 times with a 8.0 weekly interval (240.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 457.3, "avg_administrations": 30}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 351.1, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,152
first_seen: 2022-10-14
last_seen: 2024-02-13
first_seen_parent: 2020-11-01
last_seen_parent: 2024-11-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 11.3 weekly interval (237.3 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 22 times with a 10.4 weekly interval (228.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 231.2, "avg_administrations": 17}, {"drug": "TOFACITINIB", "avg_dose_mg": 79.2, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,125
first_seen: 2019-09-14
last_seen: 2025-09-15
first_seen_parent: 2020-08-15
last_seen_parent: 2025-07-13
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 277.7, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 9.4 weekly interval (84.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,027
first_seen: 2018-03-21
last_seen: 2024-04-16
first_seen_parent: 2020-12-19
last_seen_parent: 2024-12-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 77.6, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 6.4 weekly interval (102.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,747
first_seen: 2020-11-04
last_seen: 2025-08-01
first_seen_parent: 2018-04-17
last_seen_parent: 2024-09-03
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 67.7, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 5.4 weekly interval (102.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £22,233
first_seen: 2021-09-01
last_seen: 2024-02-06
first_seen_parent: 2019-11-02
last_seen_parent: 2025-09-16
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 344.6, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 3.9 weekly interval (46.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £21,588
first_seen: 2018-01-14
last_seen: 2024-12-06
first_seen_parent: 2019-12-08
last_seen_parent: 2025-09-15
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 455.1, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 5 times with a 7.3 weekly interval (36.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £9,846
first_seen: 2019-11-05
last_seen: 2024-05-27
first_seen_parent: 2019-10-13
last_seen_parent: 2025-08-31
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 310.6, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 23 times with a 4.0 weekly interval (92.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £28,257
first_seen: 2021-11-13
last_seen: 2025-03-28
first_seen_parent: 2017-10-18
last_seen_parent: 2024-08-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 106.9, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 7.5 weekly interval (90.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - BARICITINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,588
first_seen: 2021-03-07
last_seen: 2024-12-21
first_seen_parent: 2019-06-14
last_seen_parent: 2025-07-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 26 times with a 7.9 weekly interval (205.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 5 times with a 10.3 weekly interval (51.5 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 85.0, "avg_administrations": 18}, {"drug": "NATALIZUMAB", "avg_dose_mg": 183.6, "avg_administrations": 11}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,010
first_seen: 2019-09-07
last_seen: 2025-11-11
first_seen_parent: 2018-04-20
last_seen_parent: 2025-09-25
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 152.5, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 7.4 weekly interval (222.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £19,711
first_seen: 2019-11-28
last_seen: 2024-06-23
first_seen_parent: 2021-02-04
last_seen_parent: 2025-11-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 9.3 weekly interval (93.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 30 times with a 9.2 weekly interval (276.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 456.9, "avg_administrations": 15}, {"drug": "INFLIXIMAB", "avg_dose_mg": 462.2, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £20,644
first_seen: 2020-01-27
last_seen: 2024-08-27
first_seen_parent: 2017-02-16
last_seen_parent: 2025-08-23
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 405.3, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 16 times with a 2.0 weekly interval (32.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £6,149
first_seen: 2019-12-07
last_seen: 2025-06-14
first_seen_parent: 2017-11-14
last_seen_parent: 2024-03-28
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 98.0, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £21,377
first_seen: 2018-02-13
last_seen: 2024-10-16
first_seen_parent: 2019-09-13
last_seen_parent: 2024-02-02
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 486.5, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 22 times with a 6.5 weekly interval (143.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £26,404
first_seen: 2019-03-13
last_seen: 2024-05-14
first_seen_parent: 2017-07-08
last_seen_parent: 2024-02-22
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 77.3, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 2.2 weekly interval (46.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,534
first_seen: 2019-02-08
last_seen: 2024-07-26
first_seen_parent: 2021-03-31
last_seen_parent: 2025-11-26
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 12 times with a 2.7 weekly interval (32.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 8.5 weekly interval (68.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 83.0, "avg_administrations": 17}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 141.4, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £19,621
first_seen: 2021-06-03
last_seen: 2025-02-26
first_seen_parent: 2018-04-22
last_seen_parent: 2025-03-29
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 491.4, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 22 times with a 4.4 weekly interval (96.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £21,644
first_seen: 2019-03-02
last_seen: 2024-11-01
first_seen_parent: 2020-02-28
last_seen_parent: 2025-08-23
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 286.6, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 7.7 weekly interval (130.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £24,846
first_seen: 2021-08-24
last_seen: 2024-04-07
first_seen_parent: 2017-09-29
last_seen_parent: 2025-03-25
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 130.3, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 6.0 weekly interval (126.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £17,777
first_seen: 2019-04-17
last_seen: 2024-07-18
first_seen_parent: 2017-01-07
last_seen_parent: 2025-04-21
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 352.7, "avg_administrations": 21}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 10.8 weekly interval (248.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,989
first_seen: 2019-05-08
last_seen: 2024-08-07
first_seen_parent: 2020-03-29
last_seen_parent: 2024-02-08
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 220.1, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 23 times with a 4.5 weekly interval (103.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,396
first_seen: 2020-10-30
last_seen: 2024-09-05
first_seen_parent: 2020-04-29
last_seen_parent: 2024-01-06
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 349.7, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23 times with a 7.3 weekly interval (167.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,864
first_seen: 2021-03-31
last_seen: 2025-12-07
first_seen_parent: 2018-08-24
last_seen_parent: 2024-07-01
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 466.0, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 3.4 weekly interval (20.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £23,695
first_seen: 2018-02-27
last_seen: 2024-06-17
first_seen_parent: 2019-06-16
last_seen_parent: 2024-04-24
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 466.3, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 8.5 weekly interval (187.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,904
first_seen: 2020-03-03
last_seen: 2024-10-03
first_seen_parent: 2019-11-22
last_seen_parent: 2025-03-02
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 459.7, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 28 times with a 10.2 weekly interval (285.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £17,495
first_seen: 2020-12-22
last_seen: 2025-08-26
first_seen_parent: 2021-02-08
last_seen_parent: 2025-09-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 11.5 weekly interval (69.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 5.8 weekly interval (98.6 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 358.9, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 352.7, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,786
first_seen: 2022-06-28
last_seen: 2025-10-28
first_seen_parent: 2021-05-31
last_seen_parent: 2025-10-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 28 times with a 6.9 weekly interval (193.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 24 times with a 8.8 weekly interval (211.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 385.1, "avg_administrations": 19}, {"drug": "INFLIXIMAB", "avg_dose_mg": 495.1, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £26,168
first_seen: 2018-11-13
last_seen: 2024-07-16
first_seen_parent: 2018-12-22
last_seen_parent: 2025-04-22
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 183.7, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 7.4 weekly interval (125.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,908
first_seen: 2020-03-01
last_seen: 2024-01-01
first_seen_parent: 2020-09-13
last_seen_parent: 2024-03-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 444.1, "avg_administrations": 30}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 11.0 weekly interval (198.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,738
first_seen: 2021-02-19
last_seen: 2024-06-29
first_seen_parent: 2021-05-05
last_seen_parent: 2024-05-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 11.5 weekly interval (46.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 7.6 weekly interval (136.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 415.3, "avg_administrations": 29}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 109.5, "avg_administrations": 7}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £11,968
first_seen: 2021-10-18
last_seen: 2025-04-07
first_seen_parent: 2020-07-24
last_seen_parent: 2025-02-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 9.9 weekly interval (237.6 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 27 times with a 10.5 weekly interval (283.5 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 239.0, "avg_administrations": 17}, {"drug": "BARICITINIB", "avg_dose_mg": 373.7, "avg_administrations": 20}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,088
first_seen: 2021-08-31
last_seen: 2025-09-29
first_seen_parent: 2017-04-22
last_seen_parent: 2024-10-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 290.0, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 11.2 weekly interval (201.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £6,675
first_seen: 2019-11-12
last_seen: 2024-06-16
first_seen_parent: 2020-04-12
last_seen_parent: 2024-04-26
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 7.4 weekly interval (118.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 20 times with a 3.9 weekly interval (78.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 222.8, "avg_administrations": 12}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 291.1, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,040
first_seen: 2020-10-12
last_seen: 2025-12-14
first_seen_parent: 2017-09-13
last_seen_parent: 2024-03-25
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 134.5, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 9.2 weekly interval (220.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,925
first_seen: 2020-05-22
last_seen: 2024-05-17
first_seen_parent: 2018-06-29
last_seen_parent: 2025-02-05
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 252.6, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 30 times with a 4.8 weekly interval (144.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £4,409
first_seen: 2019-10-19
last_seen: 2024-04-16
first_seen_parent: 2020-03-13
last_seen_parent: 2024-09-30
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 309.1, "avg_administrations": 19}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 2.4 weekly interval (64.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £3,680
first_seen: 2019-01-19
last_seen: 2025-06-25
first_seen_parent: 2018-10-21
last_seen_parent: 2024-08-10
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 82.5, "avg_administrations": 20}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 8 times with a 12.0 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £5,624
first_seen: 2018-07-11
last_seen: 2025-06-21
first_seen_parent: 2018-11-08
last_seen_parent: 2025-11-20
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 448.5, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 5.6 weekly interval (162.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £22,060
first_seen: 2020-09-16
last_seen: 2024-05-12
first_seen_parent: 2019-11-03
last_seen_parent: 2025-12-10
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 351.2, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 15 times with a 10.8 weekly interval (162.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,806
first_seen: 2021-10-25
last_seen: 2024-02-13
first_seen_parent: 2020-01-30
last_seen_parent: 2025-01-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 4.2 weekly interval (75.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 25 times with a 2.3 weekly interval (57.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 469.5, "avg_administrations": 28}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 274.4, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £4,860
first_seen: 2019-09-25
last_seen: 2025-07-19
first_seen_parent: 2018-07-21
last_seen_parent: 2025-11-18
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 483.7, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 11.6 weekly interval (232.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,086
first_seen: 2020-12-16
last_seen: 2025-03-15
first_seen_parent: 2018-07-30
last_seen_parent: 2025-07-29
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 427.8, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 24 times with a 4.0 weekly interval (96.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £5,377
first_seen: 2019-11-18
last_seen: 2024-11-09
first_seen_parent: 2020-01-23
last_seen_parent: 2024-05-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 10.9 weekly interval (185.3 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 29 times with a 11.9 weekly interval (345.1 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 374.5, "avg_administrations": 8}, {"drug": "TOFACITINIB", "avg_dose_mg": 57.4, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £7,613
first_seen: 2021-02-18
last_seen: 2025-12-19
first_seen_parent: 2019-11-30
last_seen_parent: 2025-07-30
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 195.8, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 4.7 weekly interval (141.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £7,304
first_seen: 2020-10-26
last_seen: 2025-06-14
first_seen_parent: 2019-08-23
last_seen_parent: 2025-07-14
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 438.7, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 22 times with a 4.8 weekly interval (105.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,131
first_seen: 2019-04-29
last_seen: 2025-02-04
first_seen_parent: 2019-07-06
last_seen_parent: 2025-03-25
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 441.5, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 11.9 weekly interval (249.9 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £12,500
first_seen: 2019-08-24
last_seen: 2025-05-08
first_seen_parent: 2018-02-18
last_seen_parent: 2024-11-10
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 99.0, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 6 times with a 11.2 weekly interval (67.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: IBRUTINIB
cost_pp_pa: £17,108
first_seen: 2020-08-08
last_seen: 2025-12-20
first_seen_parent: 2020-05-20
last_seen_parent: 2025-03-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - IBRUTINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 10.6 weekly interval (74.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 14 times with a 2.6 weekly interval (36.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 383.6, "avg_administrations": 22}, {"drug": "IBRUTINIB", "avg_dose_mg": 476.6, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: BARICITINIB
cost_pp_pa: £9,026
first_seen: 2021-05-06
last_seen: 2024-08-27
first_seen_parent: 2018-12-06
last_seen_parent: 2025-12-04
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - BARICITINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 9 times with a 6.1 weekly interval (54.9 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 5 times with a 7.3 weekly interval (36.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 245.6, "avg_administrations": 7}, {"drug": "BARICITINIB", "avg_dose_mg": 87.5, "avg_administrations": 10}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,352
first_seen: 2019-08-30
last_seen: 2024-10-31
first_seen_parent: 2020-11-05
last_seen_parent: 2025-01-08
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 92.5, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 8.3 weekly interval (157.7 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: NIVOLUMAB
cost_pp_pa: £3,692
first_seen: 2022-01-22
last_seen: 2025-11-13
first_seen_parent: 2018-03-09
last_seen_parent: 2024-08-15
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - NIVOLUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 7.5 weekly interval (112.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 11 times with a 5.9 weekly interval (64.9 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 145.3, "avg_administrations": 27}, {"drug": "NIVOLUMAB", "avg_dose_mg": 319.1, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £17,520
first_seen: 2019-07-07
last_seen: 2024-03-24
first_seen_parent: 2020-03-12
last_seen_parent: 2024-09-28
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 239.3, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 5.4 weekly interval (129.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £6,228
first_seen: 2019-10-10
last_seen: 2024-05-19
first_seen_parent: 2020-10-12
last_seen_parent: 2024-03-18
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 6.2 weekly interval (124.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 29 times with a 3.4 weekly interval (98.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 268.6, "avg_administrations": 11}, {"drug": "NATALIZUMAB", "avg_dose_mg": 97.0, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £16,382
first_seen: 2018-07-22
last_seen: 2025-03-25
first_seen_parent: 2017-12-12
last_seen_parent: 2024-05-30
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 343.9, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 11.0 weekly interval (154.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £24,424
first_seen: 2020-11-26
last_seen: 2025-07-16
first_seen_parent: 2019-04-22
last_seen_parent: 2024-05-04
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 311.8, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 10.3 weekly interval (41.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £13,513
first_seen: 2018-12-15
last_seen: 2024-06-17
first_seen_parent: 2020-07-31
last_seen_parent: 2025-02-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 383.8, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 3.4 weekly interval (54.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £15,747
first_seen: 2020-11-27
last_seen: 2024-03-27
first_seen_parent: 2019-04-07
last_seen_parent: 2024-03-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 4 times with a 6.5 weekly interval (26.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 5 times with a 9.7 weekly interval (48.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 471.1, "avg_administrations": 10}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 151.4, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,093
first_seen: 2019-09-01
last_seen: 2025-06-27
first_seen_parent: 2020-04-02
last_seen_parent: 2024-02-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 3.8 weekly interval (114.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 17 times with a 3.5 weekly interval (59.5 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 350.5, "avg_administrations": 20}, {"drug": "USTEKINUMAB", "avg_dose_mg": 453.9, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £7,491
first_seen: 2018-05-02
last_seen: 2025-03-03
first_seen_parent: 2019-02-14
last_seen_parent: 2025-05-30
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 60.7, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 8.9 weekly interval (124.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £4,417
first_seen: 2020-03-21
last_seen: 2024-03-21
first_seen_parent: 2021-06-08
last_seen_parent: 2025-06-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 3.9 weekly interval (23.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 22 times with a 4.1 weekly interval (90.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 228.1, "avg_administrations": 27}, {"drug": "USTEKINUMAB", "avg_dose_mg": 292.6, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,975
first_seen: 2021-05-20
last_seen: 2025-02-26
first_seen_parent: 2018-03-14
last_seen_parent: 2025-01-26
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 4.4 weekly interval (114.4 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 26 times with a 6.2 weekly interval (161.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 422.1, "avg_administrations": 15}, {"drug": "RITUXIMAB", "avg_dose_mg": 249.7, "avg_administrations": 13}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,244
first_seen: 2020-01-16
last_seen: 2024-10-09
first_seen_parent: 2018-11-15
last_seen_parent: 2025-03-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 371.4, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,302
first_seen: 2022-09-01
last_seen: 2024-08-23
first_seen_parent: 2020-08-28
last_seen_parent: 2025-04-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 4.7 weekly interval (28.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 20 times with a 9.9 weekly interval (198.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 393.1, "avg_administrations": 24}, {"drug": "INFLIXIMAB", "avg_dose_mg": 181.0, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,010
first_seen: 2020-12-22
last_seen: 2025-06-03
first_seen_parent: 2017-11-23
last_seen_parent: 2024-05-21
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 118.5, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 8 times with a 11.6 weekly interval (92.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,044
first_seen: 2020-08-07
last_seen: 2025-05-24
first_seen_parent: 2018-05-16
last_seen_parent: 2024-04-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 28 times with a 11.4 weekly interval (319.2 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 12 times with a 7.1 weekly interval (85.2 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 180.6, "avg_administrations": 9}, {"drug": "INFLIXIMAB", "avg_dose_mg": 103.9, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,398
first_seen: 2020-03-26
last_seen: 2024-09-13
first_seen_parent: 2021-06-04
last_seen_parent: 2025-03-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 23 times with a 8.7 weekly interval (200.1 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 3.9 weekly interval (81.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 413.2, "avg_administrations": 13}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 167.7, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,863
first_seen: 2021-01-27
last_seen: 2024-10-03
first_seen_parent: 2017-08-08
last_seen_parent: 2024-04-11
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 285.7, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 5.2 weekly interval (20.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,799
first_seen: 2020-05-23
last_seen: 2025-05-22
first_seen_parent: 2019-03-26
last_seen_parent: 2024-02-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 12 times with a 9.6 weekly interval (115.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 4.0 weekly interval (100.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 431.2, "avg_administrations": 27}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 290.9, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £8,523
first_seen: 2018-07-20
last_seen: 2024-09-15
first_seen_parent: 2018-03-09
last_seen_parent: 2024-11-14
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 55.8, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 7.2 weekly interval (79.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,614
first_seen: 2020-01-14
last_seen: 2025-09-03
first_seen_parent: 2021-09-19
last_seen_parent: 2024-08-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 29 times with a 9.0 weekly interval (261.0 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 244.0, "avg_administrations": 9}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 481.7, "avg_administrations": 13}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,991
first_seen: 2019-12-18
last_seen: 2024-04-25
first_seen_parent: 2018-08-06
last_seen_parent: 2024-09-24
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 20 times with a 10.6 weekly interval (212.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 25 times with a 12.0 weekly interval (300.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 209.8, "avg_administrations": 24}, {"drug": "NATALIZUMAB", "avg_dose_mg": 99.1, "avg_administrations": 13}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £15,928
first_seen: 2018-09-06
last_seen: 2024-08-08
first_seen_parent: 2017-12-03
last_seen_parent: 2025-03-06
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 393.0, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 7.0 weekly interval (133.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,283
first_seen: 2019-09-06
last_seen: 2024-04-10
first_seen_parent: 2019-04-25
last_seen_parent: 2024-06-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 4.9 weekly interval (68.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 10 times with a 3.0 weekly interval (30.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 103.7, "avg_administrations": 12}, {"drug": "ADALIMUMAB", "avg_dose_mg": 357.2, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: PEMBROLIZUMAB
cost_pp_pa: £3,733
first_seen: 2019-03-16
last_seen: 2025-05-09
first_seen_parent: 2020-03-16
last_seen_parent: 2025-05-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT - PEMBROLIZUMAB

average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 6.4 weekly interval (179.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 8.9 weekly interval (258.1 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 275.0, "avg_administrations": 13}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 151.2, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,645
first_seen: 2018-08-16
last_seen: 2024-10-20
first_seen_parent: 2019-07-13
last_seen_parent: 2024-08-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 259.8, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 11 times with a 5.1 weekly interval (56.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,675
first_seen: 2018-06-27
last_seen: 2024-08-04
first_seen_parent: 2018-10-06
last_seen_parent: 2025-03-14
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 180.3, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 17 times with a 5.3 weekly interval (90.1 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,333
first_seen: 2018-05-19
last_seen: 2025-04-10
first_seen_parent: 2019-02-19
last_seen_parent: 2025-02-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 237.1, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 29 times with a 8.4 weekly interval (243.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £6,926
first_seen: 2020-02-19
last_seen: 2025-11-06
first_seen_parent: 2021-05-20
last_seen_parent: 2024-09-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 6.3 weekly interval (170.1 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 3.1 weekly interval (24.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 191.5, "avg_administrations": 14}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 237.6, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £9,962
first_seen: 2019-07-06
last_seen: 2025-05-08
first_seen_parent: 2020-03-31
last_seen_parent: 2024-05-08
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 18 times with a 11.9 weekly interval (214.2 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 7 times with a 8.4 weekly interval (58.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 237.3, "avg_administrations": 19}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 341.7, "avg_administrations": 9}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,371
first_seen: 2020-06-22
last_seen: 2024-07-10
first_seen_parent: 2019-01-15
last_seen_parent: 2024-12-31
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 474.4, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 11.2 weekly interval (179.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £13,502
first_seen: 2021-03-26
last_seen: 2024-08-09
first_seen_parent: 2020-09-11
last_seen_parent: 2025-01-30
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 3.6 weekly interval (104.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 25 times with a 8.7 weekly interval (217.5 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 245.3, "avg_administrations": 18}, {"drug": "BARICITINIB", "avg_dose_mg": 263.7, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,704
first_seen: 2021-08-23
last_seen: 2024-07-07
first_seen_parent: 2019-05-18
last_seen_parent: 2025-01-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 21 times with a 9.6 weekly interval (201.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 24 times with a 10.6 weekly interval (254.4 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 122.7, "avg_administrations": 5}, {"drug": "ADALIMUMAB", "avg_dose_mg": 237.5, "avg_administrations": 27}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £11,049
first_seen: 2020-09-12
last_seen: 2025-07-25
first_seen_parent: 2017-08-21
last_seen_parent: 2025-11-29
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 441.6, "avg_administrations": 9}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 27 times with a 3.0 weekly interval (81.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,819
first_seen: 2021-02-09
last_seen: 2024-04-16
first_seen_parent: 2020-09-15
last_seen_parent: 2024-03-18
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 91.4, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 2.5 weekly interval (45.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £16,285
first_seen: 2021-06-27
last_seen: 2024-09-20
first_seen_parent: 2017-02-26
last_seen_parent: 2025-03-01
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 261.4, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 3.9 weekly interval (85.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,009
first_seen: 2022-04-25
last_seen: 2024-11-30
first_seen_parent: 2021-02-05
last_seen_parent: 2024-02-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 13 times with a 6.4 weekly interval (83.2 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 11 times with a 9.8 weekly interval (107.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 368.2, "avg_administrations": 19}, {"drug": "ADALIMUMAB", "avg_dose_mg": 475.1, "avg_administrations": 5}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £8,592
first_seen: 2020-05-20
last_seen: 2025-12-06
first_seen_parent: 2021-06-14
last_seen_parent: 2024-06-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 2.5 weekly interval (67.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 18 times with a 4.4 weekly interval (79.2 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 226.8, "avg_administrations": 20}, {"drug": "INFLIXIMAB", "avg_dose_mg": 244.8, "avg_administrations": 21}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £10,711
first_seen: 2019-09-08
last_seen: 2024-10-15
first_seen_parent: 2018-11-12
last_seen_parent: 2024-09-09
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 462.0, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 9.5 weekly interval (256.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £5,182
first_seen: 2021-03-29
last_seen: 2024-05-24
first_seen_parent: 2019-03-22
last_seen_parent: 2024-05-29
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 10.3 weekly interval (298.7 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 6.4 weekly interval (185.6 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 122.1, "avg_administrations": 14}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 54.3, "avg_administrations": 15}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,052
first_seen: 2020-01-02
last_seen: 2024-01-10
first_seen_parent: 2021-05-17
last_seen_parent: 2025-06-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 9.2 weekly interval (165.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 6.8 weekly interval (27.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 227.5, "avg_administrations": 23}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 498.1, "avg_administrations": 29}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,534
first_seen: 2021-04-13
last_seen: 2024-11-21
first_seen_parent: 2017-09-08
last_seen_parent: 2025-04-04
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 324.8, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 11.3 weekly interval (282.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,129
first_seen: 2021-07-25
last_seen: 2024-03-17
first_seen_parent: 2020-10-07
last_seen_parent: 2025-07-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 28 times with a 9.7 weekly interval (271.6 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 11.9 weekly interval (357.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 303.1, "avg_administrations": 10}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 366.4, "avg_administrations": 8}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £13,448
first_seen: 2019-04-25
last_seen: 2025-06-16
first_seen_parent: 2017-07-18
last_seen_parent: 2024-06-08
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 280.4, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 9.2 weekly interval (239.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,406
first_seen: 2020-05-02
last_seen: 2024-04-03
first_seen_parent: 2020-01-12
last_seen_parent: 2025-01-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 15 times with a 4.3 weekly interval (64.5 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 20 times with a 10.3 weekly interval (206.0 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 211.9, "avg_administrations": 23}, {"drug": "USTEKINUMAB", "avg_dose_mg": 80.2, "avg_administrations": 11}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £15,067
first_seen: 2021-06-16
last_seen: 2024-09-20
first_seen_parent: 2019-04-22
last_seen_parent: 2024-05-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 134.3, "avg_administrations": 5}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 17 times with a 8.6 weekly interval (146.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,689
first_seen: 2020-06-26
last_seen: 2024-08-21
first_seen_parent: 2017-04-04
last_seen_parent: 2025-12-26
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 310.5, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 10.1 weekly interval (50.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,348
first_seen: 2020-02-16
last_seen: 2024-02-14
first_seen_parent: 2019-04-20
last_seen_parent: 2025-07-07
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 18 times with a 10.5 weekly interval (189.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 4.7 weekly interval (65.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 287.0, "avg_administrations": 28}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 276.2, "avg_administrations": 26}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £4,516
first_seen: 2019-09-03
last_seen: 2025-02-06
first_seen_parent: 2019-01-02
last_seen_parent: 2025-08-30
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 490.3, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 9.7 weekly interval (242.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,468
first_seen: 2021-02-07
last_seen: 2024-01-09
first_seen_parent: 2021-07-08
last_seen_parent: 2025-10-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 2.8 weekly interval (11.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 9.1 weekly interval (218.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 447.6, "avg_administrations": 15}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 471.5, "avg_administrations": 22}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,658
first_seen: 2020-02-20
last_seen: 2025-05-26
first_seen_parent: 2019-07-23
last_seen_parent: 2025-03-09
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 263.2, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 7.0 weekly interval (140.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £10,298
first_seen: 2019-02-28
last_seen: 2024-01-02
first_seen_parent: 2020-08-12
last_seen_parent: 2025-02-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 16 times with a 3.0 weekly interval (48.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 14 times with a 2.9 weekly interval (40.6 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 367.8, "avg_administrations": 17}, {"drug": "SECUKINUMAB", "avg_dose_mg": 304.5, "avg_administrations": 17}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £7,038
first_seen: 2019-12-05
last_seen: 2025-08-04
first_seen_parent: 2019-07-05
last_seen_parent: 2025-04-22
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 82.3, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12 times with a 10.1 weekly interval (121.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £18,887
first_seen: 2021-05-02
last_seen: 2024-11-04
first_seen_parent: 2017-01-14
last_seen_parent: 2025-02-28
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 62.1, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 3.8 weekly interval (98.8 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £9,705
first_seen: 2020-02-29
last_seen: 2024-09-22
first_seen_parent: 2020-04-13
last_seen_parent: 2025-06-12
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 414.8, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 6 times with a 6.2 weekly interval (37.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: VEDOLIZUMAB
cost_pp_pa: £22,883
first_seen: 2019-02-05
last_seen: 2025-04-25
first_seen_parent: 2019-03-30
last_seen_parent: 2025-06-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT - VEDOLIZUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 5.7 weekly interval (62.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 4 times with a 8.2 weekly interval (32.8 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 397.9, "avg_administrations": 11}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 112.9, "avg_administrations": 13}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £27,619
first_seen: 2021-05-19
last_seen: 2024-03-20
first_seen_parent: 2020-09-17
last_seen_parent: 2024-06-05
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 94.9, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 26 times with a 6.0 weekly interval (156.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £3,196
first_seen: 2020-03-14
last_seen: 2024-07-10
first_seen_parent: 2020-08-02
last_seen_parent: 2025-02-03
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 220.7, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 30 times with a 10.1 weekly interval (303.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,661
first_seen: 2018-12-13
last_seen: 2025-07-23
first_seen_parent: 2020-07-13
last_seen_parent: 2024-02-23
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 80.8, "avg_administrations": 20}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 9.5 weekly interval (161.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,093
first_seen: 2020-03-12
last_seen: 2024-04-13
first_seen_parent: 2020-01-06
last_seen_parent: 2025-01-31
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 409.5, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 25 times with a 3.7 weekly interval (92.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,005
first_seen: 2019-11-12
last_seen: 2024-01-24
first_seen_parent: 2020-07-25
last_seen_parent: 2024-05-04
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 376.6, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 8.7 weekly interval (243.6 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,047
first_seen: 2020-10-22
last_seen: 2025-06-06
first_seen_parent: 2021-02-17
last_seen_parent: 2024-11-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 7.0 weekly interval (175.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 3.1 weekly interval (34.1 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 400.0, "avg_administrations": 27}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 496.2, "avg_administrations": 25}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £12,559
first_seen: 2020-02-08
last_seen: 2024-11-19
first_seen_parent: 2017-02-08
last_seen_parent: 2025-10-30
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 57.3, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 25 times with a 6.0 weekly interval (150.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £26,055
first_seen: 2020-04-01
last_seen: 2025-05-07
first_seen_parent: 2019-12-25
last_seen_parent: 2024-04-11
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 108.4, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 17 times with a 10.2 weekly interval (173.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £11,506
first_seen: 2022-03-22
last_seen: 2025-05-04
first_seen_parent: 2020-03-24
last_seen_parent: 2024-01-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 2.1 weekly interval (16.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 10.2 weekly interval (295.8 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 497.9, "avg_administrations": 23}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 461.3, "avg_administrations": 11}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,275
first_seen: 2022-12-26
last_seen: 2025-09-07
first_seen_parent: 2019-03-06
last_seen_parent: 2025-05-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 21 times with a 9.2 weekly interval (193.2 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 30 times with a 7.4 weekly interval (222.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 430.0, "avg_administrations": 12}, {"drug": "RITUXIMAB", "avg_dose_mg": 116.4, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £14,725
first_seen: 2021-06-22
last_seen: 2024-11-08
first_seen_parent: 2019-02-11
last_seen_parent: 2025-12-15
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 355.3, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 10.4 weekly interval (83.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £22,747
first_seen: 2020-08-27
last_seen: 2024-03-13
first_seen_parent: 2019-05-19
last_seen_parent: 2024-04-29
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 142.4, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 8.0 weekly interval (152.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: INFLIXIMAB
cost_pp_pa: £16,946
first_seen: 2021-12-08
last_seen: 2025-09-19
first_seen_parent: 2019-10-05
last_seen_parent: 2025-06-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - INFLIXIMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 9.4 weekly interval (141.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 6 times with a 4.0 weekly interval (24.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 416.9, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 314.8, "avg_administrations": 30}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £5,517
first_seen: 2019-01-06
last_seen: 2024-11-17
first_seen_parent: 2021-12-17
last_seen_parent: 2024-04-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - NATALIZUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 7.1 weekly interval (78.1 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 19 times with a 7.2 weekly interval (136.8 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 390.9, "avg_administrations": 20}, {"drug": "NATALIZUMAB", "avg_dose_mg": 87.9, "avg_administrations": 18}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,250
first_seen: 2021-05-30
last_seen: 2024-05-10
first_seen_parent: 2018-09-04
last_seen_parent: 2025-08-27
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 346.8, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 5 times with a 7.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: ADALIMUMAB
cost_pp_pa: £20,230
first_seen: 2021-06-04
last_seen: 2024-12-22
first_seen_parent: 2020-05-29
last_seen_parent: 2025-04-24
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - ADALIMUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 19 times with a 8.6 weekly interval (163.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 17 times with a 9.9 weekly interval (168.3 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 296.3, "avg_administrations": 16}, {"drug": "ADALIMUMAB", "avg_dose_mg": 345.5, "avg_administrations": 14}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £15,096
first_seen: 2022-04-16
last_seen: 2024-09-28
first_seen_parent: 2021-12-28
last_seen_parent: 2024-02-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - PEMBROLIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 11.0 weekly interval (66.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 21 times with a 3.5 weekly interval (73.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 155.6, "avg_administrations": 26}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 395.1, "avg_administrations": 23}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,155
first_seen: 2020-10-07
last_seen: 2025-06-03
first_seen_parent: 2019-03-05
last_seen_parent: 2024-11-01
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 229.7, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 2.5 weekly interval (65.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,289
first_seen: 2018-07-31
last_seen: 2025-05-05
first_seen_parent: 2018-01-28
last_seen_parent: 2024-08-02
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 252.0, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 5.5 weekly interval (121.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,256
first_seen: 2021-10-18
last_seen: 2025-05-03
first_seen_parent: 2017-10-24
last_seen_parent: 2025-06-16
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 347.0, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 10 times with a 11.8 weekly interval (118.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,703
first_seen: 2018-01-12
last_seen: 2025-07-08
first_seen_parent: 2017-04-15
last_seen_parent: 2025-05-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 473.2, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 8.5 weekly interval (76.5 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,220
first_seen: 2022-02-19
last_seen: 2025-01-05
first_seen_parent: 2018-07-12
last_seen_parent: 2024-08-21
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11 times with a 2.0 weekly interval (22.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 18 times with a 8.7 weekly interval (156.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 197.6, "avg_administrations": 17}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 105.5, "avg_administrations": 19}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £13,626
first_seen: 2019-07-06
last_seen: 2025-03-20
first_seen_parent: 2018-05-17
last_seen_parent: 2025-05-22
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 11.0 weekly interval (231.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 22 times with a 10.1 weekly interval (222.2 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 483.0, "avg_administrations": 6}, {"drug": "NATALIZUMAB", "avg_dose_mg": 213.4, "avg_administrations": 12}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,776
first_seen: 2018-07-28
last_seen: 2025-04-11
first_seen_parent: 2018-02-24
last_seen_parent: 2024-06-05
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 209.0, "avg_administrations": 29}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 11 times with a 5.3 weekly interval (58.3 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £25,208
first_seen: 2019-06-16
last_seen: 2024-08-14
first_seen_parent: 2018-05-02
last_seen_parent: 2025-07-26
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 95.2, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 3.5 weekly interval (28.0 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,506
first_seen: 2018-04-10
last_seen: 2025-03-07
first_seen_parent: 2018-06-25
last_seen_parent: 2024-04-04
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 457.9, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 12 times with a 8.7 weekly interval (104.4 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,398
first_seen: 2020-12-12
last_seen: 2025-10-09
first_seen_parent: 2020-05-02
last_seen_parent: 2024-05-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 4 times with a 3.9 weekly interval (15.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 13 times with a 6.2 weekly interval (80.6 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 251.0, "avg_administrations": 22}, {"drug": "IBRUTINIB", "avg_dose_mg": 482.6, "avg_administrations": 6}]


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £17,942
first_seen: 2020-10-11
last_seen: 2025-03-20
first_seen_parent: 2017-03-02
last_seen_parent: 2025-04-23
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 323.0, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 8.2 weekly interval (90.2 weeks total treatment length)


date_filter_id: all_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,968
first_seen: 2021-09-07
last_seen: 2025-07-18
first_seen_parent: 2019-03-24
last_seen_parent: 2025-09-04
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 173.3, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 15 times with a 2.9 weekly interval (43.5 weeks total treatment length)


